[2025-10-19 05:33:21 UTC] --- REQUEST START ---
[2025-10-19 05:33:21 UTC] Flattened prompt text:
[2025-10-19 05:33:21 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: what is command to say audio in macos
Assistant:
[2025-10-19 05:33:21 UTC] JSON body:
[2025-10-19 05:33:21 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: what is command to say audio in macos\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:33:23 UTC] Final status: succeeded
[2025-10-19 05:33:23 UTC] Final response JSON:
[2025-10-19 05:33:23 UTC] {
  "id": "9rcvj3a2ysrmc0cszbtt6nd52r",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: what is command to say audio in macos\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 113\nOutput token count: 6\nTotal token count: 119\nTTFT: 0.38s\nFinish reason: stop\n",
  "output": [
    "",
    "say",
    " \"",
    "Your",
    " text",
    " here",
    "\""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:33:21.526Z",
  "started_at": "2025-10-19T05:33:21.528746492Z",
  "completed_at": "2025-10-19T05:33:22.030338837Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/9rcvj3a2ysrmc0cszbtt6nd52r/cancel",
    "get": "https://api.replicate.com/v1/predictions/9rcvj3a2ysrmc0cszbtt6nd52r",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/xezmh2d6665fksfrwv4hjy3caktg5oiht7nmxw3tn5luqeab45ba",
    "web": "https://replicate.com/p/9rcvj3a2ysrmc0cszbtt6nd52r"
  },
  "metrics": {
    "input_token_count": 113,
    "output_token_count": 6,
    "predict_time": 0.501592341,
    "time_to_first_token": 0.016290735,
    "tokens_per_second": 12.36344558892723
  }
}
[2025-10-19 05:33:23 UTC] --- REQUEST END ---

[2025-10-19 05:33:31 UTC] --- REQUEST START ---
[2025-10-19 05:33:31 UTC] Prompt: research recent news in the stock market
[2025-10-19 05:33:31 UTC] Initial response JSON:
[2025-10-19 05:33:31 UTC] {
  "id": "fnaqyy3abxrm80cszbtswd70v0",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:33:31.615Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/fnaqyy3abxrm80cszbtswd70v0/cancel",
    "get": "https://api.replicate.com/v1/predictions/fnaqyy3abxrm80cszbtswd70v0",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/j6xs7dlvfweiqekzun774de43nry2g3p5phiapbwzrtavg5vqeiq",
    "web": "https://replicate.com/p/fnaqyy3abxrm80cszbtswd70v0"
  }
}
[2025-10-19 05:33:39 UTC] Final status: succeeded
[2025-10-19 05:33:39 UTC] Final response JSON:
[2025-10-19 05:33:39 UTC] {
  "id": "fnaqyy3abxrm80cszbtswd70v0",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the stock market\nInput token count: 7\nOutput token count: 509\nTTFT: 0.66s\nTokens per second: 72.09\nTotal time: 7.06s\n",
  "output": [
    "",
    "Of course",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " recent",
    " significant",
    " news",
    " and",
    " themes",
    " moving",
    " the",
    " stock",
    " market",
    ",",
    " based",
    " on",
    " developments",
    " from",
    " late",
    " May",
    " through",
    " early",
    " June",
    " ",
    "202",
    "4",
    ".\n\n",
    "###",
    " **",
    "1",
    ".",
    " The",
    " \"",
    "Magn",
    "ific",
    "ent",
    " Seven",
    "\"",
    " and",
    " AI",
    " Fren",
    "zy",
    " Continue",
    " to",
    " Dom",
    "inate",
    "**\n\n",
    "The",
    " market",
    "'s",
    " performance",
    " is",
    " still",
    " heavily",
    " concentrated",
    " in",
    " a",
    " few",
    " mega",
    "-cap",
    " tech",
    " stocks",
    ",",
    " driven",
    " by",
    " relentless",
    " excitement",
    " around",
    " Artificial",
    " Intelligence",
    ".\n\n",
    "*",
    "  ",
    " **",
    "N",
    "VIDIA",
    " (",
    "NV",
    "DA",
    ")",
    "**:",
    " The",
    " undis",
    "puted",
    " star",
    ".",
    " Its",
    " stock",
    " has",
    " skyrock",
    "eted",
    " following",
    " an",
    " **",
    "extrem",
    "ely",
    " strong",
    " earnings",
    " report",
    "**",
    " on",
    " May",
    " ",
    "22",
    "nd",
    " that",
    " crushed",
    " expectations",
    ".",
    " The",
    " company",
    " announced",
    " a",
    " ",
    "10",
    "-for",
    "-",
    "1",
    " stock",
    " split",
    " and",
    " raised",
    " its",
    " dividend",
    ",",
    " signaling",
    " confidence",
    " in",
    " its",
    " future",
    " growth",
    ".",
    " Its",
    " performance",
    " single",
    "-hand",
    "edly",
    " lifts",
    " the",
    " entire",
    " Nasdaq",
    " and",
    " S",
    "&P",
    " ",
    "500",
    " when",
    " it",
    " rallies",
    ".\n",
    "*",
    "  ",
    " **",
    "Other",
    " Tech",
    " Giants",
    "**:",
    " Companies",
    " like",
    " **",
    "Microsoft",
    " (",
    "MS",
    "FT",
    ")",
    "**,",
    " **",
    "Al",
    "phabet",
    " (",
    "GO",
    "OG",
    "L",
    ")",
    "**,",
    " and",
    " **",
    "Meta",
    " (",
    "M",
    "ETA",
    ")**",
    " continue",
    " to",
    " invest",
    " billions",
    " in",
    " AI",
    " infrastructure",
    ",",
    " keeping",
    " investor",
    " sentiment",
    " positive",
    ".",
    " **",
    "Apple",
    " (",
    "AAP",
    "L",
    ")**",
    " also",
    " saw",
    " a",
    " boost",
    " after",
    " announcing",
    " new",
    " AI",
    " features",
    " for",
    " its",
    " products",
    " at",
    " its",
    " Worldwide",
    " Developers",
    " Conference",
    " (",
    "WW",
    "DC",
    ").\n\n",
    "**",
    "Why",
    " it",
    " matters",
    ":**",
    " These",
    " stocks",
    " are",
    " a",
    " primary",
    " driver",
    " of",
    " the",
    " major",
    " indexes",
    ".",
    " Their",
    " success",
    " creates",
    " a",
    " \"",
    "risk",
    "-on",
    "\"",
    " environment",
    " but",
    " also",
    " raises",
    " concerns",
    " about",
    " a",
    " concentrated",
    " market",
    " and",
    " high",
    " valuations",
    ".\n\n",
    "###",
    " **",
    "2",
    ".",
    " Economic",
    " Data",
    " and",
    " the",
    " \"",
    "Higher",
    " for",
    " Longer",
    "\"",
    " Interest",
    " Rate",
    " Narrative",
    "**\n\n",
    "The",
    " market",
    " is",
    " hyper",
    "-focused",
    " on",
    " economic",
    " indicators",
    ",",
    " as",
    " they",
    " directly",
    " influence",
    " the",
    " Federal",
    " Reserve",
    "'s",
    " decisions",
    " on",
    " interest",
    " rates",
    ".\n\n",
    "*",
    "  ",
    " **",
    "In",
    "flation",
    " Data",
    " (",
    "CPI",
    " &",
    " P",
    "CE",
    ")",
    "**:",
    " The",
    " latest",
    " Consumer",
    " Price",
    " Index",
    " (",
    "CPI",
    ")",
    " and",
    " Personal",
    " Consumption",
    " Expend",
    "itures",
    " (",
    "P",
    "CE",
    ")",
    " reports",
    " showed",
    " inflation",
    " cooling",
    " slightly",
    " but",
    " **",
    "remaining",
    " stubborn",
    "ly",
    " above",
    " the",
    " Fed",
    "'s",
    " ",
    "2",
    "%",
    " target",
    "**.",
    " This",
    " has",
    " reinforced",
    " the",
    " view",
    " that",
    " the",
    " Fed",
    " will",
    " not",
    " be",
    " cutting",
    " interest",
    " rates",
    " at",
    " its",
    " next",
    " meeting",
    ".\n",
    "*",
    "  ",
    " **",
    "Jobs",
    " Report",
    "**:",
    " The",
    " May",
    " jobs",
    " report",
    " came",
    " in",
    " **",
    "much",
    " stronger",
    " than",
    " expected",
    "**,",
    " showing",
    " robust",
    " hiring",
    ".",
    " While",
    " good",
    " for",
    " the",
    " economy",
    ",",
    " a",
    " strong",
    " labor",
    " market",
    " can",
    " contribute",
    " to",
    " persistent",
    " inflation",
    ",",
    " giving",
    " the",
    " Fed",
    " another",
    " reason",
    " to",
    " hold",
    " rates",
    " steady",
    ".\n",
    "*",
    "  ",
    " **",
    "Market",
    " Reaction",
    "**:",
    " As",
    " a",
    " result",
    ",",
    " Treasury",
    " yields",
    " have",
    " remained",
    " elevated",
    " (",
    "with",
    " the",
    " ",
    "10",
    "-year",
    " yield",
    " around",
    " ",
    "4",
    ".",
    "5",
    "%).",
    " This",
    " puts",
    " pressure",
    " on",
    " rate",
    "-sensitive",
    " sectors",
    " like",
    " utilities",
    " and",
    " real",
    " estate",
    ",",
    " while",
    " benef",
    "itting",
    " financial",
    "s",
    ".\n\n",
    "**",
    "Why",
    " it",
    " matters",
    ":**",
    " The",
    " expectation",
    " of",
    " \"",
    "higher",
    " for",
    " longer",
    "\"",
    " interest",
    " rates",
    " is",
    " the",
    " dominant",
    " macro",
    " theme",
    ".",
    " It",
    " strengthens",
    " the",
    " U",
    ".S",
    ".",
    " dollar",
    " and",
    " makes",
    " bonds",
    " more",
    " attractive",
    " relative",
    " to",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:33:31.615Z",
  "started_at": "2025-10-19T05:33:31.622656149Z",
  "completed_at": "2025-10-19T05:33:38.68502199Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/fnaqyy3abxrm80cszbtswd70v0/cancel",
    "get": "https://api.replicate.com/v1/predictions/fnaqyy3abxrm80cszbtswd70v0",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/j6xs7dlvfweiqekzun774de43nry2g3p5phiapbwzrtavg5vqeiq",
    "web": "https://replicate.com/p/fnaqyy3abxrm80cszbtswd70v0"
  },
  "metrics": {
    "predict_time": 7.062365841
  }
}
[2025-10-19 05:33:39 UTC] --- REQUEST END ---

[2025-10-19 05:33:59 UTC] --- REQUEST START ---
[2025-10-19 05:33:59 UTC] Prompt: research recent news in the stock market
[2025-10-19 05:33:59 UTC] Initial response JSON:
[2025-10-19 05:33:59 UTC] {
  "id": "a7vzat6rshrma0cszbts8bkkpr",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:33:59.884Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/a7vzat6rshrma0cszbts8bkkpr/cancel",
    "get": "https://api.replicate.com/v1/predictions/a7vzat6rshrma0cszbts8bkkpr",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/iq2ubxnoc3ahvqeqwx4whee7ste7xes6vxebard3ihs4arxsvwba",
    "web": "https://replicate.com/p/a7vzat6rshrma0cszbts8bkkpr"
  }
}
[2025-10-19 05:34:10 UTC] Final status: succeeded
[2025-10-19 05:34:10 UTC] Final response JSON:
[2025-10-19 05:34:10 UTC] {
  "id": "a7vzat6rshrma0cszbts8bkkpr",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the stock market\nInput token count: 7\nOutput token count: 507\nTTFT: 3.81s\nTokens per second: 55.32\nTotal time: 9.16s\n",
  "output": [
    "",
    "Of course",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " themes",
    " moving",
    " the",
    " stock",
    " market",
    ",",
    " based",
    " on",
    " information",
    " available",
    " as",
    " of",
    " late",
    " May",
    " ",
    "202",
    "4",
    ".\n\n",
    "The",
    " overarching",
    " narrative",
    " driving",
    " markets",
    " right",
    " now",
    " is",
    " a",
    " recal",
    "ibration",
    " around",
    " the",
    " **",
    "tim",
    "ing",
    " and",
    " pace",
    " of",
    " interest",
    " rate",
    " cuts",
    " by",
    " the",
    " U",
    ".S",
    ".",
    " Federal",
    " Reserve",
    " (",
    "Fed",
    ")**",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " The",
    " Federal",
    " Reserve",
    " and",
    " Inflation",
    " Data",
    " (",
    "The",
    " Biggest",
    " Driver",
    ")\n\n",
    "This",
    " is",
    " the",
    " primary",
    " force",
    " behind",
    " recent",
    " market",
    " volatility",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Key",
    " Event",
    ":**",
    " The",
    " release",
    " of",
    " the",
    " **",
    "Consumer",
    " Price",
    " Index",
    " (",
    "CPI",
    ")**",
    " report",
    " for",
    " April",
    " on",
    " May",
    " ",
    "15",
    "th",
    ".\n",
    "*",
    "  ",
    " **",
    "What",
    " Happ",
    "ened",
    ":**",
    " The",
    " report",
    " showed",
    " a",
    " slight",
    " cooling",
    " in",
    " inflation",
    ".",
    " The",
    " annual",
    " CPI",
    " rose",
    " ",
    "3",
    ".",
    "4",
    "%,",
    " down",
    " from",
    " ",
    "3",
    ".",
    "5",
    "%",
    " in",
    " March",
    ",",
    " meeting",
    " economist",
    " expectations",
    ".",
    " More",
    " importantly",
    ",",
    " \"",
    "core",
    "\"",
    " CPI",
    " (",
    "which",
    " excludes",
    " volatile",
    " food",
    " and",
    " energy",
    " prices",
    ")",
    " saw",
    " its",
    " smallest",
    " increase",
    " since",
    " December",
    " ",
    "202",
    "1",
    ".\n",
    "*",
    "  ",
    " **",
    "Market",
    " Reaction",
    ":**",
    " Stocks",
    " rallied",
    ",",
    " and",
    " bond",
    " yields",
    " fell",
    ",",
    " as",
    " the",
    " data",
    " provided",
    " evidence",
    " that",
    " inflation",
    " is",
    ",",
    " albeit",
    " slowly",
    ",",
    " res",
    "uming",
    " its",
    " downward",
    " trend",
    ".",
    " This",
    " gave",
    " investors",
    " hope",
    " that",
    " the",
    " Fed",
    " could",
    " still",
    " cut",
    " rates",
    " later",
    " this",
    " year",
    ".\n",
    "*",
    "  ",
    " **",
    "The",
    " \"",
    "Higher",
    " for",
    " Longer",
    "\"",
    " Reality",
    ":**",
    " Despite",
    " the",
    " positive",
    " data",
    ",",
    " subsequent",
    " comments",
    " from",
    " Fed",
    " officials",
    " have",
    " been",
    " cautious",
    ".",
    " The",
    " market",
    " consensus",
    " has",
    " shifted",
    " dramatically",
    " from",
    " expecting",
    " ",
    "6",
    "-",
    "7",
    " cuts",
    " at",
    " the",
    " start",
    " of",
    " the",
    " year",
    " to",
    " now",
    " pricing",
    " in",
    " only",
    " **",
    "1",
    "-",
    "2",
    " cuts",
    "**,",
    " potentially",
    " starting",
    " in",
    " September",
    " or",
    " November",
    ".",
    " This",
    " \"",
    "higher",
    " for",
    " longer",
    "\"",
    " rate",
    " environment",
    " continues",
    " to",
    " create",
    " uncertainty",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Strong",
    " Q",
    "1",
    " Earnings",
    " Season",
    "\n\n",
    "Corporate",
    " profits",
    " have",
    " largely",
    " supported",
    " current",
    " high",
    " stock",
    " valuations",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Overall",
    " Trend",
    ":**",
    " The",
    " first",
    "-quarter",
    " earnings",
    " season",
    " was",
    " surprisingly",
    " strong",
    ".",
    " According",
    " to",
    " Fact",
    "Set",
    ",",
    " nearly",
    " ",
    "80",
    "%",
    " of",
    " S",
    "&P",
    " ",
    "500",
    " companies",
    " reported",
    " a",
    " positive",
    " EPS",
    " surprise",
    ",",
    " and",
    " the",
    " blended",
    " earnings",
    " growth",
    " rate",
    " was",
    " over",
    " ",
    "5",
    "%.\n",
    "*",
    "  ",
    " **",
    "Key",
    " Stand",
    "outs",
    ":**",
    " The",
    " \"",
    "Magn",
    "ific",
    "ent",
    " ",
    "7",
    "\"",
    " tech",
    " stocks",
    " (",
    "Apple",
    ",",
    " Microsoft",
    ",",
    " Alphabet",
    ",",
    " Amazon",
    ",",
    " N",
    "vidia",
    ",",
    " Meta",
    ",",
    " Tesla",
    ")",
    " again",
    " drove",
    " a",
    " significant",
    " portion",
    " of",
    " the",
    " earnings",
    " growth",
    ",",
    " particularly",
    " N",
    "vidia",
    ",",
    " which",
    " continues",
    " to",
    " sh",
    "atter",
    " expectations",
    " due",
    " to",
    " AI",
    "-driven",
    " demand",
    " for",
    " its",
    " chips",
    ".\n",
    "*",
    "  ",
    " **",
    "Im",
    "plication",
    ":**",
    " Robust",
    " earnings",
    " have",
    " helped",
    " justify",
    " the",
    " market",
    "'s",
    " high",
    " levels",
    ",",
    " reminding",
    " investors",
    " that",
    " the",
    " rally",
    " isn",
    "'t",
    " solely",
    " based",
    " on",
    " hype",
    " but",
    " also",
    " on",
    " fundamental",
    " corporate",
    " strength",
    ".\n\n",
    "###",
    " ",
    "3",
    ".",
    " The",
    " Artificial",
    " Intelligence",
    " (",
    "AI",
    ")",
    " Boom",
    " Contin",
    "ues",
    "\n\n",
    "AI",
    " remains",
    " a",
    " powerful",
    " thematic",
    " driver",
    ",",
    " especially",
    " in",
    " the",
    " tech",
    " sector",
    ".\n\n",
    "*",
    "  ",
    " **",
    "N",
    "vidia",
    "'s",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:33:59.884Z",
  "started_at": "2025-10-19T05:33:59.892392539Z",
  "completed_at": "2025-10-19T05:34:09.058422169Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/a7vzat6rshrma0cszbts8bkkpr/cancel",
    "get": "https://api.replicate.com/v1/predictions/a7vzat6rshrma0cszbts8bkkpr",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/iq2ubxnoc3ahvqeqwx4whee7ste7xes6vxebard3ihs4arxsvwba",
    "web": "https://replicate.com/p/a7vzat6rshrma0cszbts8bkkpr"
  },
  "metrics": {
    "predict_time": 9.166029635
  }
}
[2025-10-19 05:34:10 UTC] --- REQUEST END ---

[2025-10-19 05:34:10 UTC] --- REQUEST START ---
[2025-10-19 05:34:10 UTC] Flattened prompt text:
[2025-10-19 05:34:10 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. Here is a summary of the most significant recent news and themes moving the stock market, based on information available as of late May 2024.

The overarching narrative driving markets right now is a recalibration around the **timing and pace of interest rate cuts by the U.S. Federal Reserve (Fed)**.

### 1. The Federal Reserve and Inflation Data (The Biggest Driver)

This is the primary force behind recent market volatility.

*   **Key Event:** The release of the **Consumer Price Index (CPI)** report for April on May 15th.
*   **What Happened:** The report showed a slight cooling in inflation. The annual CPI rose 3.4%, down from 3.5% in March, meeting economist expectations. More importantly, "core" CPI (which excludes volatile food and energy prices) saw its smallest increase since December 2021.
*   **Market Reaction:** Stocks rallied, and bond yields fell, as the data provided evidence that inflation is, albeit slowly, resuming its downward trend. This gave investors hope that the Fed could still cut rates later this year.
*   **The "Higher for Longer" Reality:** Despite the positive data, subsequent comments from Fed officials have been cautious. The market consensus has shifted dramatically from expecting 6-7 cuts at the start of the year to now pricing in only **1-2 cuts**, potentially starting in September or November. This "higher for longer" rate environment continues to create uncertainty.

### 2. Strong Q1 Earnings Season

Corporate profits have largely supported current high stock valuations.

*   **Overall Trend:** The first-quarter earnings season was surprisingly strong. According to FactSet, nearly 80% of S&P 500 companies reported a positive EPS surprise, and the blended earnings growth rate was over 5%.
*   **Key Standouts:** The "Magnificent 7" tech stocks (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) again drove a significant portion of the earnings growth, particularly Nvidia, which continues to shatter expectations due to AI-driven demand for its chips.
*   **Implication:** Robust earnings have helped justify the market's high levels, reminding investors that the rally isn't solely based on hype but also on fundamental corporate strength.

### 3. The Artificial Intelligence (AI) Boom Continues

AI remains a powerful thematic driver, especially in the tech sector.

*   **Nvidia's


markdown_prompt
Assistant:
[2025-10-19 05:34:10 UTC] JSON body:
[2025-10-19 05:34:10 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of the most significant recent news and themes moving the stock market, based on information available as of late May 2024.\n\nThe overarching narrative driving markets right now is a recalibration around the **timing and pace of interest rate cuts by the U.S. Federal Reserve (Fed)**.\n\n### 1. The Federal Reserve and Inflation Data (The Biggest Driver)\n\nThis is the primary force behind recent market volatility.\n\n*   **Key Event:** The release of the **Consumer Price Index (CPI)** report for April on May 15th.\n*   **What Happened:** The report showed a slight cooling in inflation. The annual CPI rose 3.4%, down from 3.5% in March, meeting economist expectations. More importantly, \"core\" CPI (which excludes volatile food and energy prices) saw its smallest increase since December 2021.\n*   **Market Reaction:** Stocks rallied, and bond yields fell, as the data provided evidence that inflation is, albeit slowly, resuming its downward trend. This gave investors hope that the Fed could still cut rates later this year.\n*   **The \"Higher for Longer\" Reality:** Despite the positive data, subsequent comments from Fed officials have been cautious. The market consensus has shifted dramatically from expecting 6-7 cuts at the start of the year to now pricing in only **1-2 cuts**, potentially starting in September or November. This \"higher for longer\" rate environment continues to create uncertainty.\n\n### 2. Strong Q1 Earnings Season\n\nCorporate profits have largely supported current high stock valuations.\n\n*   **Overall Trend:** The first-quarter earnings season was surprisingly strong. According to FactSet, nearly 80% of S&P 500 companies reported a positive EPS surprise, and the blended earnings growth rate was over 5%.\n*   **Key Standouts:** The \"Magnificent 7\" tech stocks (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) again drove a significant portion of the earnings growth, particularly Nvidia, which continues to shatter expectations due to AI-driven demand for its chips.\n*   **Implication:** Robust earnings have helped justify the market's high levels, reminding investors that the rally isn't solely based on hype but also on fundamental corporate strength.\n\n### 3. The Artificial Intelligence (AI) Boom Continues\n\nAI remains a powerful thematic driver, especially in the tech sector.\n\n*   **Nvidia's\n\n\nmarkdown_prompt\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:34:12 UTC] Final status: succeeded
[2025-10-19 05:34:12 UTC] Final response JSON:
[2025-10-19 05:34:12 UTC] {
  "id": "wbg1vr82q9rmc0cszbv8yghcag",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of the most significant recent news and themes moving the stock market, based on information available as of late May 2024.\n\nThe overarching narrative driving markets right now is a recalibration around the **timing and pace of interest rate cuts by the U.S. Federal Reserve (Fed)**.\n\n### 1. The Federal Reserve and Inflation Data (The Biggest Driver)\n\nThis is the primary force behind recent market volatility.\n\n*   **Key Event:** The release of the **Consumer Price Index (CPI)** report for April on May 15th.\n*   **What Happened:** The report showed a slight cooling in inflation. The annual CPI rose 3.4%, down from 3.5% in March, meeting economist expectations. More importantly, \"core\" CPI (which excludes volatile food and energy prices) saw its smallest increase since December 2021.\n*   **Market Reaction:** Stocks rallied, and bond yields fell, as the data provided evidence that inflation is, albeit slowly, resuming its downward trend. This gave investors hope that the Fed could still cut rates later this year.\n*   **The \"Higher for Longer\" Reality:** Despite the positive data, subsequent comments from Fed officials have been cautious. The market consensus has shifted dramatically from expecting 6-7 cuts at the start of the year to now pricing in only **1-2 cuts**, potentially starting in September or November. This \"higher for longer\" rate environment continues to create uncertainty.\n\n### 2. Strong Q1 Earnings Season\n\nCorporate profits have largely supported current high stock valuations.\n\n*   **Overall Trend:** The first-quarter earnings season was surprisingly strong. According to FactSet, nearly 80% of S&P 500 companies reported a positive EPS surprise, and the blended earnings growth rate was over 5%.\n*   **Key Standouts:** The \"Magnificent 7\" tech stocks (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, Tesla) again drove a significant portion of the earnings growth, particularly Nvidia, which continues to shatter expectations due to AI-driven demand for its chips.\n*   **Implication:** Robust earnings have helped justify the market's high levels, reminding investors that the rally isn't solely based on hype but also on fundamental corporate strength.\n\n### 3. The Artificial Intelligence (AI) Boom Continues\n\nAI remains a powerful thematic driver, especially in the tech sector.\n\n*   **Nvidia's\n\n\nmarkdown_prompt\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 604\nOutput token count: 25\nTotal token count: 629\nTTFT: 0.34s\nFinish reason: stop\n",
  "output": [
    "",
    "I'm",
    " sorry",
    ",",
    " but",
    " I",
    " can't",
    " provide",
    " a",
    " summary",
    " of",
    " recent",
    " news",
    " or",
    " themes",
    " moving",
    " the",
    " stock",
    " market",
    " as",
    " of",
    " May",
    " ",
    "202",
    "4",
    "."
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:34:10.618Z",
  "started_at": "2025-10-19T05:34:10.621362085Z",
  "completed_at": "2025-10-19T05:34:11.263743763Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/wbg1vr82q9rmc0cszbv8yghcag/cancel",
    "get": "https://api.replicate.com/v1/predictions/wbg1vr82q9rmc0cszbv8yghcag",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/ua6vxa3qsqsvfq7ydjtbqgbqol7waudny5mqkpggrcmcfkz7plmq",
    "web": "https://replicate.com/p/wbg1vr82q9rmc0cszbv8yghcag"
  },
  "metrics": {
    "input_token_count": 604,
    "output_token_count": 25,
    "predict_time": 0.642381676,
    "time_to_first_token": 0.010573089,
    "tokens_per_second": 39.56894621946631
  }
}
[2025-10-19 05:34:12 UTC] --- REQUEST END ---

[2025-10-19 05:36:50 UTC] --- REQUEST START ---
[2025-10-19 05:36:50 UTC] Prompt: research recent news in the stock market
[2025-10-19 05:36:50 UTC] Initial response JSON:
[2025-10-19 05:36:50 UTC] {
  "id": "ffzs1pvk0hrm80cszbwafvst28",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:36:50.436Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/ffzs1pvk0hrm80cszbwafvst28/cancel",
    "get": "https://api.replicate.com/v1/predictions/ffzs1pvk0hrm80cszbwafvst28",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/svwdudwotr36awuqyhavg45liknz5zp7qbtxetm4wle7rxhr2oea",
    "web": "https://replicate.com/p/ffzs1pvk0hrm80cszbwafvst28"
  }
}
[2025-10-19 05:36:56 UTC] Final status: succeeded
[2025-10-19 05:36:56 UTC] Final response JSON:
[2025-10-19 05:36:56 UTC] {
  "id": "ffzs1pvk0hrm80cszbwafvst28",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the stock market\nInput token count: 7\nOutput token count: 506\nTTFT: 0.92s\nTokens per second: 89.29\nTotal time: 5.67s\n",
  "output": [
    "",
    "Of course",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " themes",
    " driving",
    " the",
    " stock",
    " market",
    ",",
    " focusing",
    " on",
    " the",
    " past",
    " few",
    " weeks",
    ".\n\n",
    "###",
    " Top",
    " Overall",
    " Themes",
    "\n\n",
    "1",
    ".",
    " ",
    " **",
    "In",
    "flation",
    " &",
    " The",
    " Federal",
    " Reserve",
    ":**",
    " This",
    " remains",
    " the",
    " dominant",
    " story",
    ".",
    " Recent",
    " data",
    " has",
    " been",
    " mixed",
    ",",
    " leading",
    " to",
    " uncertainty",
    " about",
    " the",
    " timing",
    " and",
    " number",
    " of",
    " potential",
    " interest",
    " rate",
    " cuts",
    " in",
    " ",
    "202",
    "4",
    ".\n",
    "2",
    ".",
    " ",
    " **",
    "AI",
    " Man",
    "ia",
    " Contin",
    "ues",
    ":**",
    " The",
    " rally",
    " in",
    " artificial",
    " intelligence",
    "-related",
    " stocks",
    ",",
    " particularly",
    " semiconductor",
    " companies",
    " like",
    " NVIDIA",
    ",",
    " remains",
    " a",
    " powerful",
    " force",
    ",",
    " though",
    " it",
    " shows",
    " signs",
    " of",
    " volatility",
    ".\n",
    "3",
    ".",
    " ",
    " **",
    "Q",
    "1",
    " Earnings",
    " Season",
    ":**",
    " Corporate",
    " earnings",
    " reports",
    " for",
    " the",
    " first",
    " quarter",
    " of",
    " ",
    "202",
    "4",
    " are",
    " wrapping",
    " up",
    ".",
    " The",
    " market",
    " has",
    " been",
    " highly",
    " sensitive",
    " to",
    " companies",
    " that",
    " beat",
    " or",
    " miss",
    " expectations",
    " and",
    ",",
    " more",
    " importantly",
    ",",
    " their",
    " future",
    " guidance",
    ".\n",
    "4",
    ".",
    " ",
    " **",
    "\"M",
    "eme",
    " Stock",
    "\"",
    " Res",
    "urgence",
    ":**",
    " There",
    " has",
    " been",
    " a",
    " surprising",
    " return",
    " of",
    " extreme",
    " volatility",
    " in",
    " so",
    "-called",
    " \"",
    "m",
    "eme",
    " stocks",
    "\"",
    " like",
    " **",
    "Game",
    "Stop",
    " (",
    "G",
    "ME",
    ")**",
    " and",
    " **",
    "AM",
    "C",
    " Entertainment",
    " (",
    "AM",
    "C",
    ")",
    "**,",
    " driven",
    " by",
    " social",
    " media",
    " and",
    " retail",
    " traders",
    ".\n\n",
    "---\n\n",
    "###",
    " Key",
    " Recent",
    " Events",
    " and",
    " News",
    "\n\n",
    "####",
    " ",
    "1",
    ".",
    " Game",
    "Stop",
    " (",
    "G",
    "ME",
    ")",
    " and",
    " Mem",
    "e",
    " Stock",
    " Fren",
    "zy",
    "\n",
    "*",
    "  ",
    " **",
    "What",
    " Happ",
    "ened",
    ":**",
    " In",
    " mid",
    "-May",
    ",",
    " a",
    " social",
    " media",
    " post",
    " by",
    " \"",
    "Ro",
    "aring",
    " Kitty",
    "\"",
    " (",
    "Keith",
    " Gill",
    "),",
    " the",
    " key",
    " figure",
    " behind",
    " the",
    " ",
    "202",
    "1",
    " Game",
    "Stop",
    " short",
    " squeeze",
    ",",
    " returned",
    " after",
    " a",
    " three",
    "-year",
    " silence",
    ".",
    " This",
    " triggered",
    " an",
    " enormous",
    ",",
    " viral",
    " buying",
    " frenzy",
    " among",
    " retail",
    " investors",
    ".\n",
    "*",
    "  ",
    " **",
    "Impact",
    ":**",
    " G",
    "ME",
    " stock",
    " skyrock",
    "eted",
    ",",
    " rising",
    " over",
    " ",
    "300",
    "%",
    " in",
    " a",
    " matter",
    " of",
    " days",
    ".",
    " This",
    " volatility",
    " spilled",
    " over",
    " into",
    " other",
    " meme",
    " stocks",
    " like",
    " AM",
    "C",
    " and",
    " K",
    "oss",
    " Corp",
    " (",
    "K",
    "OSS",
    ").",
    " The",
    " event",
    " caused",
    " massive",
    " losses",
    " for",
    " short",
    " sellers",
    " and",
    " raised",
    " questions",
    " about",
    " market",
    " stability",
    " and",
    " the",
    " influence",
    " of",
    " social",
    " media",
    ".\n",
    "*",
    "  ",
    " **",
    "Latest",
    ":**",
    " The",
    " frenzy",
    " has",
    " significantly",
    " cooled",
    ",",
    " but",
    " the",
    " stocks",
    " remain",
    " highly",
    " volatile",
    " and",
    " well",
    " above",
    " their",
    " pre",
    "-s",
    "quee",
    "ze",
    " prices",
    ".",
    " It",
    " serves",
    " as",
    " a",
    " reminder",
    " of",
    " the",
    " power",
    " of",
    " retail",
    " trader",
    " communities",
    ".\n\n",
    "####",
    " ",
    "2",
    ".",
    " NVIDIA",
    "'s",
    " (",
    "NV",
    "DA",
    ")",
    " Block",
    "buster",
    " Earnings",
    " (",
    "May",
    " ",
    "22",
    "nd",
    ")\n",
    "*",
    "  ",
    " **",
    "What",
    " Happ",
    "ened",
    ":**",
    " The",
    " AI",
    " chip",
    " leader",
    " reported",
    " staggering",
    " fiscal",
    " first",
    "-quarter",
    " earnings",
    " that",
    " smashed",
    " expectations",
    ".",
    " Revenue",
    " tri",
    "pled",
    " from",
    " a",
    " year",
    " earlier",
    ",",
    " and",
    " the",
    " company",
    " announced",
    " a",
    " ",
    "10",
    "-for",
    "-",
    "1",
    " stock",
    " split",
    ".\n",
    "*",
    "  ",
    " **",
    "Impact",
    ":**",
    " The",
    " report",
    " single",
    "-hand",
    "edly",
    " lifted",
    " the",
    " entire",
    " market",
    ",",
    " especially",
    " the",
    " tech",
    " sector",
    " and",
    " the",
    " Nasdaq",
    ".",
    " It",
    " reaff",
    "irmed",
    " that",
    " the",
    " demand",
    " for",
    " AI",
    " infrastructure",
    " is",
    " not",
    " just",
    " strong",
    " but",
    " accelerating",
    ".",
    " The",
    " stock",
    " hit",
    " a",
    " new",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:36:50.436Z",
  "started_at": "2025-10-19T05:36:50.443730676Z",
  "completed_at": "2025-10-19T05:36:56.112591814Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/ffzs1pvk0hrm80cszbwafvst28/cancel",
    "get": "https://api.replicate.com/v1/predictions/ffzs1pvk0hrm80cszbwafvst28",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/svwdudwotr36awuqyhavg45liknz5zp7qbtxetm4wle7rxhr2oea",
    "web": "https://replicate.com/p/ffzs1pvk0hrm80cszbwafvst28"
  },
  "metrics": {
    "predict_time": 5.6688611380000005
  }
}
[2025-10-19 05:36:56 UTC] --- REQUEST END ---

[2025-10-19 05:36:56 UTC] --- REQUEST START ---
[2025-10-19 05:36:56 UTC] Flattened prompt text:
[2025-10-19 05:36:56 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. Here is a summary of some of the most significant recent news and themes driving the stock market, focusing on the past few weeks.

### Top Overall Themes

1.  **Inflation & The Federal Reserve:** This remains the dominant story. Recent data has been mixed, leading to uncertainty about the timing and number of potential interest rate cuts in 2024.
2.  **AI Mania Continues:** The rally in artificial intelligence-related stocks, particularly semiconductor companies like NVIDIA, remains a powerful force, though it shows signs of volatility.
3.  **Q1 Earnings Season:** Corporate earnings reports for the first quarter of 2024 are wrapping up. The market has been highly sensitive to companies that beat or miss expectations and, more importantly, their future guidance.
4.  **"Meme Stock" Resurgence:** There has been a surprising return of extreme volatility in so-called "meme stocks" like **GameStop (GME)** and **AMC Entertainment (AMC)**, driven by social media and retail traders.

---

### Key Recent Events and News

#### 1. GameStop (GME) and Meme Stock Frenzy
*   **What Happened:** In mid-May, a social media post by "Roaring Kitty" (Keith Gill), the key figure behind the 2021 GameStop short squeeze, returned after a three-year silence. This triggered an enormous, viral buying frenzy among retail investors.
*   **Impact:** GME stock skyrocketed, rising over 300% in a matter of days. This volatility spilled over into other meme stocks like AMC and Koss Corp (KOSS). The event caused massive losses for short sellers and raised questions about market stability and the influence of social media.
*   **Latest:** The frenzy has significantly cooled, but the stocks remain highly volatile and well above their pre-squeeze prices. It serves as a reminder of the power of retail trader communities.

#### 2. NVIDIA's (NVDA) Blockbuster Earnings (May 22nd)
*   **What Happened:** The AI chip leader reported staggering fiscal first-quarter earnings that smashed expectations. Revenue tripled from a year earlier, and the company announced a 10-for-1 stock split.
*   **Impact:** The report single-handedly lifted the entire market, especially the tech sector and the Nasdaq. It reaffirmed that the demand for AI infrastructure is not just strong but accelerating. The stock hit a new


Please format this text block as markdown
Assistant:
[2025-10-19 05:36:56 UTC] JSON body:
[2025-10-19 05:36:56 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of some of the most significant recent news and themes driving the stock market, focusing on the past few weeks.\n\n### Top Overall Themes\n\n1.  **Inflation & The Federal Reserve:** This remains the dominant story. Recent data has been mixed, leading to uncertainty about the timing and number of potential interest rate cuts in 2024.\n2.  **AI Mania Continues:** The rally in artificial intelligence-related stocks, particularly semiconductor companies like NVIDIA, remains a powerful force, though it shows signs of volatility.\n3.  **Q1 Earnings Season:** Corporate earnings reports for the first quarter of 2024 are wrapping up. The market has been highly sensitive to companies that beat or miss expectations and, more importantly, their future guidance.\n4.  **\"Meme Stock\" Resurgence:** There has been a surprising return of extreme volatility in so-called \"meme stocks\" like **GameStop (GME)** and **AMC Entertainment (AMC)**, driven by social media and retail traders.\n\n---\n\n### Key Recent Events and News\n\n#### 1. GameStop (GME) and Meme Stock Frenzy\n*   **What Happened:** In mid-May, a social media post by \"Roaring Kitty\" (Keith Gill), the key figure behind the 2021 GameStop short squeeze, returned after a three-year silence. This triggered an enormous, viral buying frenzy among retail investors.\n*   **Impact:** GME stock skyrocketed, rising over 300% in a matter of days. This volatility spilled over into other meme stocks like AMC and Koss Corp (KOSS). The event caused massive losses for short sellers and raised questions about market stability and the influence of social media.\n*   **Latest:** The frenzy has significantly cooled, but the stocks remain highly volatile and well above their pre-squeeze prices. It serves as a reminder of the power of retail trader communities.\n\n#### 2. NVIDIA's (NVDA) Blockbuster Earnings (May 22nd)\n*   **What Happened:** The AI chip leader reported staggering fiscal first-quarter earnings that smashed expectations. Revenue tripled from a year earlier, and the company announced a 10-for-1 stock split.\n*   **Impact:** The report single-handedly lifted the entire market, especially the tech sector and the Nasdaq. It reaffirmed that the demand for AI infrastructure is not just strong but accelerating. The stock hit a new\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:37:01 UTC] Final status: succeeded
[2025-10-19 05:37:01 UTC] Final response JSON:
[2025-10-19 05:37:01 UTC] {
  "id": "bhc2bf4cyxrme0cszbwatyn5cc",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of some of the most significant recent news and themes driving the stock market, focusing on the past few weeks.\n\n### Top Overall Themes\n\n1.  **Inflation & The Federal Reserve:** This remains the dominant story. Recent data has been mixed, leading to uncertainty about the timing and number of potential interest rate cuts in 2024.\n2.  **AI Mania Continues:** The rally in artificial intelligence-related stocks, particularly semiconductor companies like NVIDIA, remains a powerful force, though it shows signs of volatility.\n3.  **Q1 Earnings Season:** Corporate earnings reports for the first quarter of 2024 are wrapping up. The market has been highly sensitive to companies that beat or miss expectations and, more importantly, their future guidance.\n4.  **\"Meme Stock\" Resurgence:** There has been a surprising return of extreme volatility in so-called \"meme stocks\" like **GameStop (GME)** and **AMC Entertainment (AMC)**, driven by social media and retail traders.\n\n---\n\n### Key Recent Events and News\n\n#### 1. GameStop (GME) and Meme Stock Frenzy\n*   **What Happened:** In mid-May, a social media post by \"Roaring Kitty\" (Keith Gill), the key figure behind the 2021 GameStop short squeeze, returned after a three-year silence. This triggered an enormous, viral buying frenzy among retail investors.\n*   **Impact:** GME stock skyrocketed, rising over 300% in a matter of days. This volatility spilled over into other meme stocks like AMC and Koss Corp (KOSS). The event caused massive losses for short sellers and raised questions about market stability and the influence of social media.\n*   **Latest:** The frenzy has significantly cooled, but the stocks remain highly volatile and well above their pre-squeeze prices. It serves as a reminder of the power of retail trader communities.\n\n#### 2. NVIDIA's (NVDA) Blockbuster Earnings (May 22nd)\n*   **What Happened:** The AI chip leader reported staggering fiscal first-quarter earnings that smashed expectations. Revenue tripled from a year earlier, and the company announced a 10-for-1 stock split.\n*   **Impact:** The report single-handedly lifted the entire market, especially the tech sector and the Nasdaq. It reaffirmed that the demand for AI infrastructure is not just strong but accelerating. The stock hit a new\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 607\nOutput token count: 457\nTotal token count: 1064\nTTFT: 0.30s\nFinish reason: stop\n",
  "output": [
    "",
    "###",
    " Top",
    " Overall",
    " Themes",
    "\n\n",
    "1",
    ".",
    " **",
    "Infl",
    "ation",
    " &",
    " The",
    " Federal",
    " Reserve",
    ":**",
    " This",
    " remains",
    " the",
    " dominant",
    " story",
    ".",
    " Recent",
    " data",
    " has",
    " been",
    " mixed",
    ",",
    " leading",
    " to",
    " uncertainty",
    " about",
    " the",
    " timing",
    " and",
    " number",
    " of",
    " potential",
    " interest",
    " rate",
    " cuts",
    " in",
    " ",
    "202",
    "4",
    ".\n",
    "2",
    ".",
    " **",
    "AI",
    " Mania",
    " Contin",
    "ues",
    ":**",
    " The",
    " rally",
    " in",
    " artificial",
    " intelligence",
    "-related",
    " stocks",
    ",",
    " particularly",
    " semiconductor",
    " companies",
    " like",
    " NVIDIA",
    ",",
    " remains",
    " a",
    " powerful",
    " force",
    ",",
    " though",
    " it",
    " shows",
    " signs",
    " of",
    " volatility",
    ".\n",
    "3",
    ".",
    " **",
    "Q",
    "1",
    " Earnings",
    " Season",
    ":**",
    " Corporate",
    " earnings",
    " reports",
    " for",
    " the",
    " first",
    " quarter",
    " of",
    " ",
    "202",
    "4",
    " are",
    " wrapping",
    " up",
    ".",
    " The",
    " market",
    " has",
    " been",
    " highly",
    " sensitive",
    " to",
    " companies",
    " that",
    " beat",
    " or",
    " miss",
    " expectations",
    " and",
    ",",
    " more",
    " importantly",
    ",",
    " their",
    " future",
    " guidance",
    ".\n",
    "4",
    ".",
    " **",
    "\"",
    "M",
    "eme",
    " Stock",
    "\"",
    " Res",
    "urgence",
    ":**",
    " There",
    " has",
    " been",
    " a",
    " surprising",
    " return",
    " of",
    " extreme",
    " volatility",
    " in",
    " so",
    "-called",
    " \"",
    "m",
    "eme",
    " stocks",
    "\"",
    " like",
    " **",
    "Game",
    "Stop",
    " (",
    "G",
    "ME",
    ")**",
    " and",
    " **",
    "AMC",
    " Entertainment",
    " (",
    "AMC",
    ")**",
    ",",
    " driven",
    " by",
    " social",
    " media",
    " and",
    " retail",
    " traders",
    ".\n\n",
    "---\n\n",
    "###",
    " Key",
    " Recent",
    " Events",
    " and",
    " News",
    "\n\n",
    "####",
    " ",
    "1",
    ".",
    " Game",
    "Stop",
    " (",
    "G",
    "ME",
    ")",
    " and",
    " Meme",
    " Stock",
    " Fren",
    "zy",
    "\n",
    "*",
    " **",
    "What",
    " Happ",
    "ened",
    ":**",
    " In",
    " mid",
    "-May",
    ",",
    " a",
    " social",
    " media",
    " post",
    " by",
    " \"",
    "Ro",
    "aring",
    " Kitty",
    "\"",
    " (",
    "Keith",
    " Gill",
    "),",
    " the",
    " key",
    " figure",
    " behind",
    " the",
    " ",
    "202",
    "1",
    " Game",
    "Stop",
    " short",
    " squeeze",
    ",",
    " returned",
    " after",
    " a",
    " three",
    "-year",
    " silence",
    ".",
    " This",
    " triggered",
    " an",
    " enormous",
    ",",
    " viral",
    " buying",
    " frenzy",
    " among",
    " retail",
    " investors",
    ".\n",
    "*",
    " **",
    "Impact",
    ":**",
    " G",
    "ME",
    " stock",
    " skyrock",
    "eted",
    ",",
    " rising",
    " over",
    " ",
    "300",
    "%",
    " in",
    " a",
    " matter",
    " of",
    " days",
    ".",
    " This",
    " volatility",
    " spilled",
    " over",
    " into",
    " other",
    " meme",
    " stocks",
    " like",
    " AMC",
    " and",
    " K",
    "oss",
    " Corp",
    " (",
    "K",
    "OSS",
    ").",
    " The",
    " event",
    " caused",
    " massive",
    " losses",
    " for",
    " short",
    " sellers",
    " and",
    " raised",
    " questions",
    " about",
    " market",
    " stability",
    " and",
    " the",
    " influence",
    " of",
    " social",
    " media",
    ".\n",
    "*",
    " **",
    "Latest",
    ":**",
    " The",
    " frenzy",
    " has",
    " significantly",
    " cooled",
    ",",
    " but",
    " the",
    " stocks",
    " remain",
    " highly",
    " volatile",
    " and",
    " well",
    " above",
    " their",
    " pre",
    "-s",
    "queeze",
    " prices",
    ".",
    " It",
    " serves",
    " as",
    " a",
    " reminder",
    " of",
    " the",
    " power",
    " of",
    " retail",
    " trader",
    " communities",
    ".\n\n",
    "####",
    " ",
    "2",
    ".",
    " NVIDIA",
    "'s",
    " (",
    "NV",
    "DA",
    ")",
    " Block",
    "buster",
    " Earnings",
    " (",
    "May",
    " ",
    "22",
    "nd",
    ")\n",
    "*",
    " **",
    "What",
    " Happ",
    "ened",
    ":**",
    " The",
    " AI",
    " chip",
    " leader",
    " reported",
    " staggering",
    " fiscal",
    " first",
    "-quarter",
    " earnings",
    " that",
    " smashed",
    " expectations",
    ".",
    " Revenue",
    " trip",
    "led",
    " from",
    " a",
    " year",
    " earlier",
    ",",
    " and",
    " the",
    " company",
    " announced",
    " a",
    " ",
    "10",
    "-for",
    "-",
    "1",
    " stock",
    " split",
    ".\n",
    "*",
    " **",
    "Impact",
    ":**",
    " The",
    " report",
    " single",
    "-handed",
    "ly",
    " lifted",
    " the",
    " entire",
    " market",
    ",",
    " especially",
    " the",
    " tech",
    " sector",
    " and",
    " the",
    " Nasdaq",
    ".",
    " It",
    " reaffirm",
    "ed",
    " that",
    " the",
    " demand",
    " for",
    " AI",
    " infrastructure",
    " is",
    " not",
    " just",
    " strong",
    " but",
    " accelerating",
    ".",
    " The",
    " stock",
    " hit",
    " a",
    " new"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:36:57.079Z",
  "started_at": "2025-10-19T05:36:57.082100248Z",
  "completed_at": "2025-10-19T05:36:59.674679755Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/bhc2bf4cyxrme0cszbwatyn5cc/cancel",
    "get": "https://api.replicate.com/v1/predictions/bhc2bf4cyxrme0cszbwatyn5cc",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/yhyept44phncjmmfnmy2kdaathsvx4uanzeghwup6hi2gsjdqbva",
    "web": "https://replicate.com/p/bhc2bf4cyxrme0cszbwatyn5cc"
  },
  "metrics": {
    "input_token_count": 607,
    "output_token_count": 457,
    "predict_time": 2.592579507,
    "time_to_first_token": 0.033533454,
    "tokens_per_second": 178.58217106497693
  }
}
[2025-10-19 05:37:01 UTC] --- REQUEST END ---

[2025-10-19 05:38:15 UTC] --- REQUEST START ---
[2025-10-19 05:38:15 UTC] Prompt: research recent news in the stock market
[2025-10-19 05:38:15 UTC] Initial response JSON:
[2025-10-19 05:38:15 UTC] {
  "id": "kxcf56nzfxrmc0cszbwsdkwvrc",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:38:15.551Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/kxcf56nzfxrmc0cszbwsdkwvrc/cancel",
    "get": "https://api.replicate.com/v1/predictions/kxcf56nzfxrmc0cszbwsdkwvrc",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/rt5d4wuuyrorlncz2f6hpilcuc6c7vxo63emqrj3jkbgtaoaeiyq",
    "web": "https://replicate.com/p/kxcf56nzfxrmc0cszbwsdkwvrc"
  }
}
[2025-10-19 05:38:21 UTC] Final status: succeeded
[2025-10-19 05:38:21 UTC] Final response JSON:
[2025-10-19 05:38:21 UTC] {
  "id": "kxcf56nzfxrmc0cszbwsdkwvrc",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the stock market",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the stock market\nInput token count: 7\nOutput token count: 506\nTTFT: 0.86s\nTokens per second: 112.70\nTotal time: 4.49s\n",
  "output": [
    "",
    "Of course",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " themes",
    " driving",
    " the",
    " stock",
    " market",
    ",",
    " focusing",
    " on",
    " the",
    " last",
    " week",
    " of",
    " May",
    " ",
    "202",
    "4",
    ".\n\n",
    "The",
    " market",
    " is",
    " currently",
    " being",
    " dominated",
    " by",
    " three",
    " major",
    " themes",
    ":",
    " **",
    "AI",
    " Man",
    "ia",
    "**,",
    " **",
    "Interest",
    " Rate",
    " Uncertainty",
    "**,",
    " and",
    " **",
    "Key",
    " Earnings",
    " Reports",
    "**.\n\n",
    "###",
    " ",
    "1",
    ".",
    " The",
    " Artificial",
    " Intelligence",
    " (",
    "AI",
    ")",
    " Fren",
    "zy",
    " Contin",
    "ues",
    "\n\n",
    "This",
    " remains",
    " the",
    " single",
    " biggest",
    " driver",
    " of",
    " market",
    " sentiment",
    " and",
    " specific",
    " stock",
    " movements",
    ".\n\n",
    "*",
    "  ",
    " **",
    "N",
    "VIDIA",
    " (",
    "NV",
    "DA",
    ")",
    " Earnings",
    " Bl",
    "ow",
    "out",
    ":**",
    " Last",
    " week",
    ",",
    " NVIDIA",
    " delivered",
    " staggering",
    " quarterly",
    " results",
    " that",
    " far",
    " exceeded",
    " Wall",
    " Street",
    "'s",
    " high",
    " expectations",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Revenue",
    ":**",
    " $",
    "26",
    " billion",
    " vs",
    ".",
    " expected",
    " $",
    "24",
    ".",
    "6",
    " billion",
    " (",
    "up",
    " ",
    "262",
    "%",
    " year",
    "-over",
    "-year",
    ").\n",
    "   ",
    " *",
    "  ",
    " **",
    "Data",
    " Center",
    " Revenue",
    ":**",
    " $",
    "22",
    ".",
    "6",
    " billion",
    " (",
    "up",
    " ",
    "427",
    "%",
    "!",
    ").\n",
    "   ",
    " *",
    "  ",
    " The",
    " company",
    " also",
    " announced",
    " a",
    " **",
    "10",
    "-for",
    "-",
    "1",
    " stock",
    " split",
    "**",
    " and",
    " raised",
    " its",
    " dividend",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Impact",
    ":**",
    " NVIDIA",
    "'s",
    " success",
    " is",
    " seen",
    " as",
    " a",
    " direct",
    " proxy",
    " for",
    " the",
    " entire",
    " AI",
    " infrastructure",
    " boom",
    ".",
    " Its",
    " strong",
    " guidance",
    " reassured",
    " the",
    " market",
    " that",
    " demand",
    " for",
    " AI",
    " chips",
    " and",
    " systems",
    " is",
    " not",
    " slowing",
    " down",
    ".",
    " This",
    " boosted",
    " the",
    " entire",
    " tech",
    " sector",
    ",",
    " especially",
    " semiconductor",
    " stocks",
    " (",
    "like",
    " AMD",
    ",",
    " SM",
    "CI",
    ")",
    " and",
    " other",
    " AI",
    "-related",
    " companies",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Other",
    " AI",
    " Benef",
    "ici",
    "aries",
    ":**",
    " Companies",
    " linked",
    " to",
    " the",
    " AI",
    " supply",
    " chain",
    ",",
    " such",
    " as",
    " **",
    "Super",
    " Micro",
    " Computer",
    " (",
    "SM",
    "CI",
    ")**",
    " and",
    " **",
    "Advanced",
    " Micro",
    " Devices",
    " (",
    "AMD",
    ")",
    "**,",
    " have",
    " seen",
    " their",
    " stocks",
    " rally",
    " on",
    " the",
    " co",
    "att",
    "ails",
    " of",
    " NVIDIA",
    "'s",
    " success",
    ".",
    " Cloud",
    " providers",
    " like",
    " **",
    "Microsoft",
    " (",
    "MS",
    "FT",
    ")",
    "**,",
    " **",
    "Amazon",
    " (",
    "AM",
    "ZN",
    ")",
    "**,",
    " and",
    " **",
    "Google",
    " (",
    "GO",
    "OG",
    "L",
    ")**",
    " are",
    " also",
    " viewed",
    " as",
    " long",
    "-term",
    " winners",
    " as",
    " they",
    " build",
    " out",
    " massive",
    " AI",
    " data",
    " centers",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Conf",
    "licting",
    " Signals",
    " on",
    " Interest",
    " Rates",
    " &",
    " The",
    " \"",
    "Higher",
    " for",
    " Longer",
    "\"",
    " Narrative",
    "\n\n",
    "The",
    " Federal",
    " Reserve",
    "'s",
    " policy",
    " on",
    " interest",
    " rates",
    " is",
    " the",
    " macro",
    "-economic",
    " backdrop",
    " for",
    " everything",
    ".\n\n",
    "*",
    "  ",
    " **",
    "H",
    "awk",
    "ish",
    " Fed",
    " Minutes",
    ":**",
    " The",
    " minutes",
    " from",
    " the",
    " Fed",
    "'s",
    " latest",
    " meeting",
    ",",
    " released",
    " this",
    " week",
    ",",
    " showed",
    " that",
    " **",
    "o",
    "ffic",
    "ials",
    " are",
    " concerned",
    " about",
    " persistent",
    " inflation",
    "**",
    " and",
    " are",
    " not",
    " confident",
    " enough",
    " to",
    " start",
    " cutting",
    " rates",
    ".",
    " Several",
    " officials",
    " even",
    " mentioned",
    " a",
    " willingness",
    " to",
    " *",
    "raise",
    "*",
    " rates",
    " further",
    " if",
    " necessary",
    ".\n",
    "*",
    "  ",
    " **",
    "Strong",
    " Economic",
    " Data",
    ":**",
    " Recent",
    " data",
    ",",
    " including",
    " the",
    " S",
    "&P",
    " Global",
    " PM",
    "I",
    ",",
    " has",
    " shown",
    " the",
    " U",
    ".S",
    ".",
    " economy",
    " remains",
    " surprisingly",
    " resilient",
    ".",
    " While",
    " this",
    " is",
    " good",
    " news",
    ",",
    " it",
    " also",
    " means",
    " the",
    " Fed",
    " feels",
    " less",
    " pressure",
    " to",
    " cut",
    " rates",
    " to",
    " stimulate",
    " the",
    " economy",
    ".\n",
    "*",
    "  ",
    " **",
    "Market",
    " Reaction",
    ":**",
    " This",
    " \"",
    "higher",
    " for",
    " longer",
    "\"",
    " message",
    " has",
    " caused",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:38:15.551Z",
  "started_at": "2025-10-19T05:38:15.558457762Z",
  "completed_at": "2025-10-19T05:38:20.049825917Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/kxcf56nzfxrmc0cszbwsdkwvrc/cancel",
    "get": "https://api.replicate.com/v1/predictions/kxcf56nzfxrmc0cszbwsdkwvrc",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/rt5d4wuuyrorlncz2f6hpilcuc6c7vxo63emqrj3jkbgtaoaeiyq",
    "web": "https://replicate.com/p/kxcf56nzfxrmc0cszbwsdkwvrc"
  },
  "metrics": {
    "predict_time": 4.491368159
  }
}
[2025-10-19 05:38:21 UTC] --- REQUEST END ---

[2025-10-19 05:38:21 UTC] --- REQUEST START ---
[2025-10-19 05:38:21 UTC] Flattened prompt text:
[2025-10-19 05:38:21 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. Here is a summary of the most significant recent news and themes driving the stock market, focusing on the last week of May 2024.

The market is currently being dominated by three major themes: **AI Mania**, **Interest Rate Uncertainty**, and **Key Earnings Reports**.

### 1. The Artificial Intelligence (AI) Frenzy Continues

This remains the single biggest driver of market sentiment and specific stock movements.

*   **NVIDIA (NVDA) Earnings Blowout:** Last week, NVIDIA delivered staggering quarterly results that far exceeded Wall Street's high expectations.
    *   **Revenue:** $26 billion vs. expected $24.6 billion (up 262% year-over-year).
    *   **Data Center Revenue:** $22.6 billion (up 427%!).
    *   The company also announced a **10-for-1 stock split** and raised its dividend.
    *   **Impact:** NVIDIA's success is seen as a direct proxy for the entire AI infrastructure boom. Its strong guidance reassured the market that demand for AI chips and systems is not slowing down. This boosted the entire tech sector, especially semiconductor stocks (like AMD, SMCI) and other AI-related companies.

*   **Other AI Beneficiaries:** Companies linked to the AI supply chain, such as **Super Micro Computer (SMCI)** and **Advanced Micro Devices (AMD)**, have seen their stocks rally on the coattails of NVIDIA's success. Cloud providers like **Microsoft (MSFT)**, **Amazon (AMZN)**, and **Google (GOOGL)** are also viewed as long-term winners as they build out massive AI data centers.

### 2. Conflicting Signals on Interest Rates & The "Higher for Longer" Narrative

The Federal Reserve's policy on interest rates is the macro-economic backdrop for everything.

*   **Hawkish Fed Minutes:** The minutes from the Fed's latest meeting, released this week, showed that **officials are concerned about persistent inflation** and are not confident enough to start cutting rates. Several officials even mentioned a willingness to *raise* rates further if necessary.
*   **Strong Economic Data:** Recent data, including the S&P Global PMI, has shown the U.S. economy remains surprisingly resilient. While this is good news, it also means the Fed feels less pressure to cut rates to stimulate the economy.
*   **Market Reaction:** This "higher for longer" message has caused


Please format this text block as markdown
Assistant:
[2025-10-19 05:38:21 UTC] JSON body:
[2025-10-19 05:38:21 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of the most significant recent news and themes driving the stock market, focusing on the last week of May 2024.\n\nThe market is currently being dominated by three major themes: **AI Mania**, **Interest Rate Uncertainty**, and **Key Earnings Reports**.\n\n### 1. The Artificial Intelligence (AI) Frenzy Continues\n\nThis remains the single biggest driver of market sentiment and specific stock movements.\n\n*   **NVIDIA (NVDA) Earnings Blowout:** Last week, NVIDIA delivered staggering quarterly results that far exceeded Wall Street's high expectations.\n    *   **Revenue:** $26 billion vs. expected $24.6 billion (up 262% year-over-year).\n    *   **Data Center Revenue:** $22.6 billion (up 427%!).\n    *   The company also announced a **10-for-1 stock split** and raised its dividend.\n    *   **Impact:** NVIDIA's success is seen as a direct proxy for the entire AI infrastructure boom. Its strong guidance reassured the market that demand for AI chips and systems is not slowing down. This boosted the entire tech sector, especially semiconductor stocks (like AMD, SMCI) and other AI-related companies.\n\n*   **Other AI Beneficiaries:** Companies linked to the AI supply chain, such as **Super Micro Computer (SMCI)** and **Advanced Micro Devices (AMD)**, have seen their stocks rally on the coattails of NVIDIA's success. Cloud providers like **Microsoft (MSFT)**, **Amazon (AMZN)**, and **Google (GOOGL)** are also viewed as long-term winners as they build out massive AI data centers.\n\n### 2. Conflicting Signals on Interest Rates & The \"Higher for Longer\" Narrative\n\nThe Federal Reserve's policy on interest rates is the macro-economic backdrop for everything.\n\n*   **Hawkish Fed Minutes:** The minutes from the Fed's latest meeting, released this week, showed that **officials are concerned about persistent inflation** and are not confident enough to start cutting rates. Several officials even mentioned a willingness to *raise* rates further if necessary.\n*   **Strong Economic Data:** Recent data, including the S&P Global PMI, has shown the U.S. economy remains surprisingly resilient. While this is good news, it also means the Fed feels less pressure to cut rates to stimulate the economy.\n*   **Market Reaction:** This \"higher for longer\" message has caused\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:38:26 UTC] Final status: succeeded
[2025-10-19 05:38:26 UTC] Final response JSON:
[2025-10-19 05:38:26 UTC] {
  "id": "71rdm6yrgdrma0cszbwtgkxhyr",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. Here is a summary of the most significant recent news and themes driving the stock market, focusing on the last week of May 2024.\n\nThe market is currently being dominated by three major themes: **AI Mania**, **Interest Rate Uncertainty**, and **Key Earnings Reports**.\n\n### 1. The Artificial Intelligence (AI) Frenzy Continues\n\nThis remains the single biggest driver of market sentiment and specific stock movements.\n\n*   **NVIDIA (NVDA) Earnings Blowout:** Last week, NVIDIA delivered staggering quarterly results that far exceeded Wall Street's high expectations.\n    *   **Revenue:** $26 billion vs. expected $24.6 billion (up 262% year-over-year).\n    *   **Data Center Revenue:** $22.6 billion (up 427%!).\n    *   The company also announced a **10-for-1 stock split** and raised its dividend.\n    *   **Impact:** NVIDIA's success is seen as a direct proxy for the entire AI infrastructure boom. Its strong guidance reassured the market that demand for AI chips and systems is not slowing down. This boosted the entire tech sector, especially semiconductor stocks (like AMD, SMCI) and other AI-related companies.\n\n*   **Other AI Beneficiaries:** Companies linked to the AI supply chain, such as **Super Micro Computer (SMCI)** and **Advanced Micro Devices (AMD)**, have seen their stocks rally on the coattails of NVIDIA's success. Cloud providers like **Microsoft (MSFT)**, **Amazon (AMZN)**, and **Google (GOOGL)** are also viewed as long-term winners as they build out massive AI data centers.\n\n### 2. Conflicting Signals on Interest Rates & The \"Higher for Longer\" Narrative\n\nThe Federal Reserve's policy on interest rates is the macro-economic backdrop for everything.\n\n*   **Hawkish Fed Minutes:** The minutes from the Fed's latest meeting, released this week, showed that **officials are concerned about persistent inflation** and are not confident enough to start cutting rates. Several officials even mentioned a willingness to *raise* rates further if necessary.\n*   **Strong Economic Data:** Recent data, including the S&P Global PMI, has shown the U.S. economy remains surprisingly resilient. While this is good news, it also means the Fed feels less pressure to cut rates to stimulate the economy.\n*   **Market Reaction:** This \"higher for longer\" message has caused\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 610\nOutput token count: 503\nTotal token count: 1113\nTTFT: 0.40s\nFinish reason: stop\n",
  "output": [
    "",
    "``",
    "`\n",
    "Of",
    " course",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " themes",
    " driving",
    " the",
    " stock",
    " market",
    ",",
    " focusing",
    " on",
    " the",
    " last",
    " week",
    " of",
    " May",
    " ",
    "202",
    "4",
    ".\n\n",
    "The",
    " market",
    " is",
    " currently",
    " being",
    " dominated",
    " by",
    " three",
    " major",
    " themes",
    ":",
    " **",
    "AI",
    " Mania",
    "**,",
    " **",
    "Interest",
    " Rate",
    " Un",
    "certainty",
    "**,",
    " and",
    " **",
    "Key",
    " Earnings",
    " Reports",
    "**",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " The",
    " Artificial",
    " Intelligence",
    " (",
    "AI",
    ")",
    " Fren",
    "zy",
    " Contin",
    "ues",
    "\n\n",
    "This",
    " remains",
    " the",
    " single",
    " biggest",
    " driver",
    " of",
    " market",
    " sentiment",
    " and",
    " specific",
    " stock",
    " movements",
    ".\n\n",
    "*",
    "  ",
    " **",
    "N",
    "VIDIA",
    " (",
    "NV",
    "DA",
    ")",
    " Earnings",
    " Blow",
    "out",
    ":**",
    " Last",
    " week",
    ",",
    " NVIDIA",
    " delivered",
    " staggering",
    " quarterly",
    " results",
    " that",
    " far",
    " exceeded",
    " Wall",
    " Street",
    "'s",
    " high",
    " expectations",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Revenue",
    ":**",
    " $",
    "26",
    " billion",
    " vs",
    ".",
    " expected",
    " $",
    "24",
    ".",
    "6",
    " billion",
    " (",
    "up",
    " ",
    "262",
    "%",
    " year",
    "-over",
    "-year",
    ").\n",
    "   ",
    " *",
    "  ",
    " **",
    "Data",
    " Center",
    " Revenue",
    ":**",
    " $",
    "22",
    ".",
    "6",
    " billion",
    " (",
    "up",
    " ",
    "427",
    "%!",
    ").\n",
    "   ",
    " *",
    "  ",
    " The",
    " company",
    " also",
    " announced",
    " a",
    " **",
    "10",
    "-for",
    "-",
    "1",
    " stock",
    " split",
    "**",
    " and",
    " raised",
    " its",
    " dividend",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Impact",
    ":**",
    " NVIDIA",
    "'s",
    " success",
    " is",
    " seen",
    " as",
    " a",
    " direct",
    " proxy",
    " for",
    " the",
    " entire",
    " AI",
    " infrastructure",
    " boom",
    ".",
    " Its",
    " strong",
    " guidance",
    " reass",
    "ured",
    " the",
    " market",
    " that",
    " demand",
    " for",
    " AI",
    " chips",
    " and",
    " systems",
    " is",
    " not",
    " slowing",
    " down",
    ".",
    " This",
    " boosted",
    " the",
    " entire",
    " tech",
    " sector",
    ",",
    " especially",
    " semiconductor",
    " stocks",
    " (",
    "like",
    " AMD",
    ",",
    " SM",
    "CI",
    ")",
    " and",
    " other",
    " AI",
    "-related",
    " companies",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Other",
    " AI",
    " Benef",
    "ici",
    "aries",
    ":**",
    " Companies",
    " linked",
    " to",
    " the",
    " AI",
    " supply",
    " chain",
    ",",
    " such",
    " as",
    " **",
    "Super",
    " Micro",
    " Computer",
    " (",
    "SM",
    "CI",
    ")**",
    " and",
    " **",
    "Advanced",
    " Micro",
    " Devices",
    " (",
    "AMD",
    ")**",
    ",",
    " have",
    " seen",
    " their",
    " stocks",
    " rally",
    " on",
    " the",
    " co",
    "att",
    "ails",
    " of",
    " NVIDIA",
    "'s",
    " success",
    ".",
    " Cloud",
    " providers",
    " like",
    " **",
    "Microsoft",
    " (",
    "MS",
    "FT",
    ")**",
    ",",
    " **",
    "Amazon",
    " (",
    "AM",
    "ZN",
    ")**",
    ",",
    " and",
    " **",
    "Google",
    " (",
    "GO",
    "O",
    "GL",
    ")**",
    " are",
    " also",
    " viewed",
    " as",
    " long",
    "-term",
    " winners",
    " as",
    " they",
    " build",
    " out",
    " massive",
    " AI",
    " data",
    " centers",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Conf",
    "licting",
    " Signals",
    " on",
    " Interest",
    " Rates",
    " &",
    " The",
    " \"",
    "Higher",
    " for",
    " Longer",
    "\"",
    " Narrative",
    "\n\n",
    "The",
    " Federal",
    " Reserve",
    "'s",
    " policy",
    " on",
    " interest",
    " rates",
    " is",
    " the",
    " macro",
    "-economic",
    " backdrop",
    " for",
    " everything",
    ".\n\n",
    "*",
    "  ",
    " **",
    "H",
    "awk",
    "ish",
    " Fed",
    " Minutes",
    ":**",
    " The",
    " minutes",
    " from",
    " the",
    " Fed",
    "'s",
    " latest",
    " meeting",
    ",",
    " released",
    " this",
    " week",
    ",",
    " showed",
    " that",
    " **",
    "official",
    "s",
    " are",
    " concerned",
    " about",
    " persistent",
    " inflation",
    "**",
    " and",
    " are",
    " not",
    " confident",
    " enough",
    " to",
    " start",
    " cutting",
    " rates",
    ".",
    " Several",
    " officials",
    " even",
    " mentioned",
    " a",
    " willingness",
    " to",
    " *",
    "raise",
    "*",
    " rates",
    " further",
    " if",
    " necessary",
    ".\n",
    "*",
    "  ",
    " **",
    "Strong",
    " Economic",
    " Data",
    ":**",
    " Recent",
    " data",
    ",",
    " including",
    " the",
    " S",
    "&P",
    " Global",
    " PMI",
    ",",
    " has",
    " shown",
    " the",
    " U",
    ".S",
    ".",
    " economy",
    " remains",
    " surprisingly",
    " resilient",
    ".",
    " While",
    " this",
    " is",
    " good",
    " news",
    ",",
    " it",
    " also",
    " means",
    " the",
    " Fed",
    " feels",
    " less",
    " pressure",
    " to",
    " cut",
    " rates",
    " to",
    " stimulate",
    " the",
    " economy",
    ".\n",
    "*",
    "  ",
    " **",
    "Market",
    " Reaction",
    ":**",
    " This",
    " \"",
    "higher",
    " for",
    " longer",
    "\"",
    " message",
    " has",
    " caused",
    "\n",
    "``",
    "`\n"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:38:21.955Z",
  "started_at": "2025-10-19T05:38:21.958506138Z",
  "completed_at": "2025-10-19T05:38:25.774208358Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/71rdm6yrgdrma0cszbwtgkxhyr/cancel",
    "get": "https://api.replicate.com/v1/predictions/71rdm6yrgdrma0cszbwtgkxhyr",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/7eribb2nasazod3hevx3ob4xj5ebc37kop4cz3w2p46fjqkcxgpq",
    "web": "https://replicate.com/p/71rdm6yrgdrma0cszbwtgkxhyr"
  },
  "metrics": {
    "input_token_count": 610,
    "output_token_count": 503,
    "predict_time": 3.81570222,
    "time_to_first_token": 0.015280374,
    "tokens_per_second": 132.35372818662617
  }
}
[2025-10-19 05:38:26 UTC] --- REQUEST END ---

[2025-10-19 05:39:15 UTC] --- REQUEST START ---
[2025-10-19 05:39:15 UTC] Prompt: research recent news in the biochemical space
[2025-10-19 05:39:15 UTC] Initial response JSON:
[2025-10-19 05:39:15 UTC] {
  "id": "ryssrena9srme0cszbx82386a8",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:39:15.662Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/ryssrena9srme0cszbx82386a8/cancel",
    "get": "https://api.replicate.com/v1/predictions/ryssrena9srme0cszbx82386a8",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/vgybwyfkg5xlosedon3r4gkc57cobqptedmpwqj5w7w3k5za6qma",
    "web": "https://replicate.com/p/ryssrena9srme0cszbx82386a8"
  }
}
[2025-10-19 05:39:21 UTC] Final status: succeeded
[2025-10-19 05:39:21 UTC] Final response JSON:
[2025-10-19 05:39:21 UTC] {
  "id": "ryssrena9srme0cszbx82386a8",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the biochemical space\nInput token count: 7\nOutput token count: 519\nTTFT: 0.63s\nTokens per second: 86.45\nTotal time: 6.00s\n",
  "output": [
    "",
    "Of course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " breakthroughs",
    " happening",
    " weekly",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " trends",
    ",",
    " categorized",
    " for",
    " clarity",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " in",
    " Drug",
    " Discovery",
    " &",
    " Protein",
    " Design",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " most",
    " transformative",
    " trend",
    " in",
    " biochemistry",
    " right",
    " now",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Deep",
    "Mind",
    "'s",
    " Alpha",
    "Fold",
    " ",
    "3",
    " (",
    "May",
    " ",
    "202",
    "4",
    "):",
    "**",
    " Google",
    " Deep",
    "Mind",
    " and",
    " Is",
    "omorphic",
    " Labs",
    " released",
    " Alpha",
    "Fold",
    " ",
    "3",
    ",",
    " a",
    " monumental",
    " leap",
    " in",
    " predictive",
    " biology",
    ".",
    " Unlike",
    " its",
    " predecessor",
    " (",
    "which",
    " predicted",
    " protein",
    " structures",
    "),",
    " Alpha",
    "Fold",
    " ",
    "3",
    " can",
    " predict",
    " the",
    " structure",
    " and",
    " interaction",
    " of",
    " nearly",
    " all",
    " of",
    " life",
    "'s",
    " molecules",
    "\u2014",
    "pro",
    "teins",
    ",",
    " DNA",
    ",",
    " RNA",
    ",",
    " ligands",
    ",",
    " ions",
    ",",
    " and",
    " modified",
    " residues",
    " (",
    "like",
    " phosphory",
    "lated",
    " proteins",
    ").",
    " This",
    " provides",
    " an",
    " unprecedented",
    " view",
    " of",
    " cellular",
    " processes",
    " and",
    " will",
    " dramatically",
    " accelerate",
    " drug",
    " discovery",
    " by",
    " predicting",
    " how",
    " a",
    " potential",
    " drug",
    " compound",
    " (",
    "lig",
    "and",
    ")",
    " will",
    " bind",
    " to",
    " its",
    " target",
    ".\n",
    "*",
    "  ",
    " **",
    "AI",
    "-D",
    "is",
    "covered",
    " Drugs",
    " Enter",
    "ing",
    " Clinical",
    " Trials",
    ":**",
    " Companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "a",
    " Deep",
    "Mind",
    " spin",
    "-off",
    "),",
    " **",
    "Ex",
    "s",
    "cient",
    "ia",
    "**,",
    " and",
    " **",
    "Rec",
    "ursion",
    " Pharmaceuticals",
    "**",
    " are",
    " pushing",
    " AI",
    "-designed",
    " drugs",
    " into",
    " the",
    " clinic",
    ".",
    " For",
    " example",
    ",",
    " Ex",
    "s",
    "cient",
    "ia",
    " has",
    " several",
    " molecules",
    " in",
    " Phase",
    " ",
    "1",
    "/",
    "2",
    " trials",
    " for",
    " cancer",
    " and",
    " inflammatory",
    " diseases",
    " that",
    " were",
    " largely",
    " designed",
    " by",
    " AI",
    ",",
    " significantly",
    " shortening",
    " the",
    " pre",
    "-cl",
    "inical",
    " development",
    " timeline",
    ".\n",
    "*",
    "  ",
    " **",
    "Gener",
    "ative",
    " AI",
    " for",
    " Novel",
    " Protein",
    " Design",
    ":**",
    " Researchers",
    " are",
    " using",
    " generative",
    " AI",
    " models",
    " (",
    "similar",
    " to",
    " ChatGPT",
    " but",
    " for",
    " proteins",
    ")",
    " to",
    " design",
    " entirely",
    " new",
    " proteins",
    " with",
    " specific",
    " functions",
    ".",
    " This",
    " has",
    " applications",
    " in",
    " creating",
    " new",
    " enzymes",
    " for",
    " bioc",
    "atal",
    "ysis",
    ",",
    " developing",
    " more",
    " effective",
    " protein",
    "-based",
    " therapeutics",
    ",",
    " and",
    " engineering",
    " biom",
    "aterials",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Weight",
    " Loss",
    " Drugs",
    " (",
    "GL",
    "P",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    ")",
    " and",
    " Beyond",
    "\n\n",
    "The",
    " block",
    "buster",
    " success",
    " of",
    " G",
    "LP",
    "-",
    "1",
    " agonists",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "agl",
    "ut",
    "ide",
    ")",
    " and",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "t",
    "ir",
    "z",
    "epat",
    "ide",
    ")",
    " continues",
    " to",
    " dominate",
    " pharmaceutical",
    " news",
    " and",
    " research",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Next",
    "-G",
    "eneration",
    " Multi",
    "-A",
    "gon",
    "ists",
    ":**",
    " The",
    " focus",
    " is",
    " now",
    " on",
    " developing",
    " even",
    " more",
    " effective",
    " drugs",
    ".",
    " **",
    "E",
    "li",
    " Lilly",
    "'s",
    " ret",
    "at",
    "rut",
    "ide",
    "**",
    " (",
    "a",
    " G",
    "LP",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " and",
    " gluc",
    "agon",
    " receptor",
    " triple",
    " agonist",
    ")",
    " showed",
    " outstanding",
    " results",
    " in",
    " Phase",
    " ",
    "2",
    " trials",
    ",",
    " producing",
    " up",
    " to",
    " ",
    "24",
    "%",
    " weight",
    " loss",
    " on",
    " average",
    ".",
    " **",
    "Am",
    "gen",
    "'s",
    " Mari",
    "T",
    "ide",
    "**",
    " (",
    "a",
    " G",
    "IP",
    " receptor",
    " antagonist",
    " and",
    " G",
    "LP",
    "-",
    "1",
    " agonist",
    ")",
    " also",
    " shows",
    " promising",
    " early",
    " data",
    " with",
    " a",
    " potentially",
    " different",
    " side",
    " effect",
    " and",
    " dosing",
    " profile",
    " (",
    "month",
    "ly",
    " injection",
    ").\n",
    "*",
    "  ",
    " **",
    "Exp",
    "anding",
    " Therapeutic",
    " Applications",
    ":**",
    " Major",
    " clinical",
    " trials",
    " are",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:39:15.662Z",
  "started_at": "2025-10-19T05:39:15.669204547Z",
  "completed_at": "2025-10-19T05:39:21.673774808Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/ryssrena9srme0cszbx82386a8/cancel",
    "get": "https://api.replicate.com/v1/predictions/ryssrena9srme0cszbx82386a8",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/vgybwyfkg5xlosedon3r4gkc57cobqptedmpwqj5w7w3k5za6qma",
    "web": "https://replicate.com/p/ryssrena9srme0cszbx82386a8"
  },
  "metrics": {
    "predict_time": 6.004570262
  }
}
[2025-10-19 05:39:21 UTC] --- REQUEST END ---

[2025-10-19 05:39:22 UTC] --- REQUEST START ---
[2025-10-19 05:39:22 UTC] Flattened prompt text:
[2025-10-19 05:39:22 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.

### 1. AI and Machine Learning in Drug Discovery & Protein Design

This is arguably the most transformative trend in biochemistry right now.

*   **DeepMind's AlphaFold 3 (May 2024):** Google DeepMind and Isomorphic Labs released AlphaFold 3, a monumental leap in predictive biology. Unlike its predecessor (which predicted protein structures), AlphaFold 3 can predict the structure and interaction of nearly all of life's moleculesproteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylated proteins). This provides an unprecedented view of cellular processes and will dramatically accelerate drug discovery by predicting how a potential drug compound (ligand) will bind to its target.
*   **AI-Discovered Drugs Entering Clinical Trials:** Companies like **Isomorphic Labs** (a DeepMind spin-off), **Exscientia**, and **Recursion Pharmaceuticals** are pushing AI-designed drugs into the clinic. For example, Exscientia has several molecules in Phase 1/2 trials for cancer and inflammatory diseases that were largely designed by AI, significantly shortening the pre-clinical development timeline.
*   **Generative AI for Novel Protein Design:** Researchers are using generative AI models (similar to ChatGPT but for proteins) to design entirely new proteins with specific functions. This has applications in creating new enzymes for biocatalysis, developing more effective protein-based therapeutics, and engineering biomaterials.

### 2. Weight Loss Drugs (GLP-1 Agonists) and Beyond

The blockbuster success of GLP-1 agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to dominate pharmaceutical news and research.

*   **Next-Generation Multi-Agonists:** The focus is now on developing even more effective drugs. **Eli Lilly's retatrutide** (a GLP-1, GIP, and glucagon receptor triple agonist) showed outstanding results in Phase 2 trials, producing up to 24% weight loss on average. **Amgen's MariTide** (a GIP receptor antagonist and GLP-1 agonist) also shows promising early data with a potentially different side effect and dosing profile (monthly injection).
*   **Expanding Therapeutic Applications:** Major clinical trials are


Please format this text block as markdown
Assistant:
[2025-10-19 05:39:22 UTC] JSON body:
[2025-10-19 05:39:22 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.\n\n### 1. AI and Machine Learning in Drug Discovery & Protein Design\n\nThis is arguably the most transformative trend in biochemistry right now.\n\n*   **DeepMind's AlphaFold 3 (May 2024):** Google DeepMind and Isomorphic Labs released AlphaFold 3, a monumental leap in predictive biology. Unlike its predecessor (which predicted protein structures), AlphaFold 3 can predict the structure and interaction of nearly all of life's molecules\u2014proteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylated proteins). This provides an unprecedented view of cellular processes and will dramatically accelerate drug discovery by predicting how a potential drug compound (ligand) will bind to its target.\n*   **AI-Discovered Drugs Entering Clinical Trials:** Companies like **Isomorphic Labs** (a DeepMind spin-off), **Exscientia**, and **Recursion Pharmaceuticals** are pushing AI-designed drugs into the clinic. For example, Exscientia has several molecules in Phase 1/2 trials for cancer and inflammatory diseases that were largely designed by AI, significantly shortening the pre-clinical development timeline.\n*   **Generative AI for Novel Protein Design:** Researchers are using generative AI models (similar to ChatGPT but for proteins) to design entirely new proteins with specific functions. This has applications in creating new enzymes for biocatalysis, developing more effective protein-based therapeutics, and engineering biomaterials.\n\n### 2. Weight Loss Drugs (GLP-1 Agonists) and Beyond\n\nThe blockbuster success of GLP-1 agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to dominate pharmaceutical news and research.\n\n*   **Next-Generation Multi-Agonists:** The focus is now on developing even more effective drugs. **Eli Lilly's retatrutide** (a GLP-1, GIP, and glucagon receptor triple agonist) showed outstanding results in Phase 2 trials, producing up to 24% weight loss on average. **Amgen's MariTide** (a GIP receptor antagonist and GLP-1 agonist) also shows promising early data with a potentially different side effect and dosing profile (monthly injection).\n*   **Expanding Therapeutic Applications:** Major clinical trials are\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:39:26 UTC] Final status: succeeded
[2025-10-19 05:39:26 UTC] Final response JSON:
[2025-10-19 05:39:26 UTC] {
  "id": "6b8d3rp3j1rm80cszbxaj016w4",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.\n\n### 1. AI and Machine Learning in Drug Discovery & Protein Design\n\nThis is arguably the most transformative trend in biochemistry right now.\n\n*   **DeepMind's AlphaFold 3 (May 2024):** Google DeepMind and Isomorphic Labs released AlphaFold 3, a monumental leap in predictive biology. Unlike its predecessor (which predicted protein structures), AlphaFold 3 can predict the structure and interaction of nearly all of life's molecules\u2014proteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylated proteins). This provides an unprecedented view of cellular processes and will dramatically accelerate drug discovery by predicting how a potential drug compound (ligand) will bind to its target.\n*   **AI-Discovered Drugs Entering Clinical Trials:** Companies like **Isomorphic Labs** (a DeepMind spin-off), **Exscientia**, and **Recursion Pharmaceuticals** are pushing AI-designed drugs into the clinic. For example, Exscientia has several molecules in Phase 1/2 trials for cancer and inflammatory diseases that were largely designed by AI, significantly shortening the pre-clinical development timeline.\n*   **Generative AI for Novel Protein Design:** Researchers are using generative AI models (similar to ChatGPT but for proteins) to design entirely new proteins with specific functions. This has applications in creating new enzymes for biocatalysis, developing more effective protein-based therapeutics, and engineering biomaterials.\n\n### 2. Weight Loss Drugs (GLP-1 Agonists) and Beyond\n\nThe blockbuster success of GLP-1 agonists like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to dominate pharmaceutical news and research.\n\n*   **Next-Generation Multi-Agonists:** The focus is now on developing even more effective drugs. **Eli Lilly's retatrutide** (a GLP-1, GIP, and glucagon receptor triple agonist) showed outstanding results in Phase 2 trials, producing up to 24% weight loss on average. **Amgen's MariTide** (a GIP receptor antagonist and GLP-1 agonist) also shows promising early data with a potentially different side effect and dosing profile (monthly injection).\n*   **Expanding Therapeutic Applications:** Major clinical trials are\n\n\nPlease format this text block as markdown\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 618\nOutput token count: 511\nTotal token count: 1129\nTTFT: 0.80s\nFinish reason: stop\n",
  "output": [
    "",
    "``",
    "`\n",
    "Of",
    " course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " breakthroughs",
    " happening",
    " weekly",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " trends",
    ",",
    " categorized",
    " for",
    " clarity",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " in",
    " Drug",
    " Discovery",
    " &",
    " Protein",
    " Design",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " most",
    " transformative",
    " trend",
    " in",
    " bi",
    "ochemistry",
    " right",
    " now",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Deep",
    "Mind",
    "'s",
    " Alpha",
    "Fold",
    " ",
    "3",
    " (",
    "May",
    " ",
    "202",
    "4",
    "):",
    "**",
    " Google",
    " Deep",
    "Mind",
    " and",
    " Is",
    "omorphic",
    " Labs",
    " released",
    " Alpha",
    "Fold",
    " ",
    "3",
    ",",
    " a",
    " monumental",
    " leap",
    " in",
    " predictive",
    " biology",
    ".",
    " Unlike",
    " its",
    " predecessor",
    " (",
    "which",
    " predicted",
    " protein",
    " structures",
    "),",
    " Alpha",
    "Fold",
    " ",
    "3",
    " can",
    " predict",
    " the",
    " structure",
    " and",
    " interaction",
    " of",
    " nearly",
    " all",
    " of",
    " life's",
    " molecules",
    "\u2014",
    "prote",
    "ins",
    ",",
    " DNA",
    ",",
    " RNA",
    ",",
    " lig",
    "ands",
    ",",
    " ions",
    ",",
    " and",
    " modified",
    " residues",
    " (",
    "like",
    " phosphory",
    "lated",
    " proteins",
    ").",
    " This",
    " provides",
    " an",
    " unprecedented",
    " view",
    " of",
    " cellular",
    " processes",
    " and",
    " will",
    " dramatically",
    " accelerate",
    " drug",
    " discovery",
    " by",
    " predicting",
    " how",
    " a",
    " potential",
    " drug",
    " compound",
    " (",
    "lig",
    "and",
    ")",
    " will",
    " bind",
    " to",
    " its",
    " target",
    ".\n",
    "*",
    "  ",
    " **",
    "AI",
    "-",
    "Dis",
    "covered",
    " Drugs",
    " Enter",
    "ing",
    " Clinical",
    " Trials",
    ":**",
    " Companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "a",
    " Deep",
    "Mind",
    " spin",
    "-off",
    "),",
    " **",
    "Ex",
    "scient",
    "ia",
    "**,",
    " and",
    " **",
    "Rec",
    "ursion",
    " Pharmaceuticals",
    "**",
    " are",
    " pushing",
    " AI",
    "-designed",
    " drugs",
    " into",
    " the",
    " clinic",
    ".",
    " For",
    " example",
    ",",
    " Ex",
    "scient",
    "ia",
    " has",
    " several",
    " molecules",
    " in",
    " Phase",
    " ",
    "1",
    "/",
    "2",
    " trials",
    " for",
    " cancer",
    " and",
    " inflammatory",
    " diseases",
    " that",
    " were",
    " largely",
    " designed",
    " by",
    " AI",
    ",",
    " significantly",
    " shortening",
    " the",
    " pre",
    "-cl",
    "in",
    "ical",
    " development",
    " timeline",
    ".\n",
    "*",
    "  ",
    " **",
    "Gener",
    "ative",
    " AI",
    " for",
    " Novel",
    " Protein",
    " Design",
    ":**",
    " Researchers",
    " are",
    " using",
    " gener",
    "ative",
    " AI",
    " models",
    " (",
    "similar",
    " to",
    " Chat",
    "GPT",
    " but",
    " for",
    " proteins",
    ")",
    " to",
    " design",
    " entirely",
    " new",
    " proteins",
    " with",
    " specific",
    " functions",
    ".",
    " This",
    " has",
    " applications",
    " in",
    " creating",
    " new",
    " enzymes",
    " for",
    " bi",
    "oc",
    "atal",
    "ysis",
    ",",
    " developing",
    " more",
    " effective",
    " protein",
    "-based",
    " therapeut",
    "ics",
    ",",
    " and",
    " engineering",
    " biom",
    "aterials",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Weight",
    " Loss",
    " Drugs",
    " (",
    "GL",
    "P",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    ")",
    " and",
    " Beyond",
    "\n\n",
    "The",
    " blockbuster",
    " success",
    " of",
    " GL",
    "P",
    "-",
    "1",
    " agon",
    "ists",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "ag",
    "lut",
    "ide",
    ")",
    " and",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "tir",
    "zep",
    "at",
    "ide",
    ")",
    " continues",
    " to",
    " dominate",
    " pharmaceutical",
    " news",
    " and",
    " research",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Next",
    "-",
    "Generation",
    " Multi",
    "-",
    "Ag",
    "on",
    "ists",
    ":**",
    " The",
    " focus",
    " is",
    " now",
    " on",
    " developing",
    " even",
    " more",
    " effective",
    " drugs",
    ".",
    " **",
    "E",
    "li",
    " Lilly",
    "'s",
    " ret",
    "atr",
    "ut",
    "ide",
    "**",
    " (",
    "a",
    " GL",
    "P",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " and",
    " gluc",
    "agon",
    " receptor",
    " triple",
    " agon",
    "ist",
    ")",
    " showed",
    " outstanding",
    " results",
    " in",
    " Phase",
    " ",
    "2",
    " trials",
    ",",
    " producing",
    " up",
    " to",
    " ",
    "24",
    "%",
    " weight",
    " loss",
    " on",
    " average",
    ".",
    " **",
    "Am",
    "gen",
    "'s",
    " Mari",
    "T",
    "ide",
    "**",
    " (",
    "a",
    " G",
    "IP",
    " receptor",
    " antagonist",
    " and",
    " GL",
    "P",
    "-",
    "1",
    " agon",
    "ist",
    ")",
    " also",
    " shows",
    " promising",
    " early",
    " data",
    " with",
    " a",
    " potentially",
    " different",
    " side",
    " effect",
    " and",
    " dosing",
    " profile",
    " (",
    "monthly",
    " injection",
    ").\n",
    "*",
    "  ",
    " **",
    "Exp",
    "anding",
    " Therapeut",
    "ic",
    " Applications",
    ":**",
    " Major",
    " clinical",
    " trials",
    " are",
    "\n",
    "``",
    "`\n"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:39:22.128Z",
  "started_at": "2025-10-19T05:39:22.132139491Z",
  "completed_at": "2025-10-19T05:39:24.740243557Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/6b8d3rp3j1rm80cszbxaj016w4/cancel",
    "get": "https://api.replicate.com/v1/predictions/6b8d3rp3j1rm80cszbxaj016w4",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/xsfbzmegdb7zavlfuwmkp47rmj7e3xzchyza3yx7gcha2mwevveq",
    "web": "https://replicate.com/p/6b8d3rp3j1rm80cszbxaj016w4"
  },
  "metrics": {
    "input_token_count": 618,
    "output_token_count": 511,
    "predict_time": 2.608104066,
    "time_to_first_token": 0.071246779,
    "tokens_per_second": 201.43032980948288
  }
}
[2025-10-19 05:39:26 UTC] --- REQUEST END ---

[2025-10-19 05:40:56 UTC] --- REQUEST START ---
[2025-10-19 05:40:56 UTC] Prompt: research recent news in the biochemical space
[2025-10-19 05:40:56 UTC] Initial response JSON:
[2025-10-19 05:40:56 UTC] {
  "id": "tbaawh9n9xrma0cszbybwjgqe0",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:40:56.783Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/tbaawh9n9xrma0cszbybwjgqe0/cancel",
    "get": "https://api.replicate.com/v1/predictions/tbaawh9n9xrma0cszbybwjgqe0",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/zh4uajpbbap6z3je6w337qmcwlcwlin3tj75dfmu67x3s7pjmova",
    "web": "https://replicate.com/p/tbaawh9n9xrma0cszbybwjgqe0"
  }
}
[2025-10-19 05:41:05 UTC] Final status: succeeded
[2025-10-19 05:41:05 UTC] Final response JSON:
[2025-10-19 05:41:05 UTC] {
  "id": "tbaawh9n9xrma0cszbybwjgqe0",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the biochemical space\nInput token count: 7\nOutput token count: 517\nTTFT: 0.96s\nTokens per second: 76.94\nTotal time: 6.72s\n",
  "output": [
    "",
    "Of course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " breakthroughs",
    " happening",
    " across",
    " medicine",
    ",",
    " sustainability",
    ",",
    " and",
    " fundamental",
    " research",
    ".",
    " Here",
    " are",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " stories",
    " and",
    " trends",
    ",",
    " broken",
    " down",
    " by",
    " category",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " Revolution",
    "izing",
    " Discovery",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " biggest",
    " overarching",
    " trend",
    ",",
    " accelerating",
    " progress",
    " in",
    " all",
    " other",
    " areas",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Google",
    " Deep",
    "Mind",
    "'s",
    " Alpha",
    "Fold",
    " ",
    "3",
    ":**",
    " In",
    " a",
    " landmark",
    " paper",
    " published",
    " in",
    " *",
    "Nature",
    "*",
    " in",
    " May",
    " ",
    "202",
    "4",
    ",",
    " Deep",
    "Mind",
    " unveiled",
    " Alpha",
    "Fold",
    " ",
    "3",
    ".",
    " This",
    " is",
    " a",
    " massive",
    " leap",
    " from",
    " its",
    " predecessor",
    ".",
    " While",
    " Alpha",
    "Fold",
    " ",
    "2",
    " predicted",
    " protein",
    " structures",
    " with",
    " stunning",
    " accuracy",
    ",",
    " **",
    "Alpha",
    "Fold",
    " ",
    "3",
    " predicts",
    " the",
    " structure",
    " and",
    " interactions",
    " of",
    " nearly",
    " all",
    " of",
    " life",
    "'s",
    " molecules",
    "**",
    "\u2014",
    "pro",
    "teins",
    ",",
    " DNA",
    ",",
    " RNA",
    ",",
    " ligands",
    ",",
    " ions",
    ",",
    " and",
    " modified",
    " residues",
    " (",
    "like",
    " phosphorylation",
    ").\n",
    "   ",
    " *",
    "  ",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " This",
    " allows",
    " researchers",
    " to",
    " model",
    " complete",
    " biological",
    " pathways",
    " and",
    " drug",
    "-target",
    " interactions",
    " with",
    " unprecedented",
    " precision",
    ",",
    " dramatically",
    " speeding",
    " up",
    " drug",
    " discovery",
    " and",
    " basic",
    " biological",
    " understanding",
    ".\n",
    "*",
    "  ",
    " **",
    "AI",
    "-Driven",
    " Drug",
    " Discovery",
    ":**",
    " Companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "an",
    " Alphabet",
    " spin",
    "-off",
    " from",
    " Deep",
    "Mind",
    ")",
    " are",
    " now",
    " signing",
    " massive",
    " deals",
    " with",
    " ph",
    "arma",
    " giants",
    " (",
    "e",
    ".g",
    ".,",
    " Eli",
    " Lilly",
    ",",
    " Nov",
    "art",
    "is",
    ")",
    " potentially",
    " worth",
    " over",
    " $",
    "1",
    ".",
    "5",
    " billion",
    " to",
    " discover",
    " new",
    " therapeutics",
    " using",
    " their",
    " AI",
    " platforms",
    ".",
    " This",
    " signifies",
    " a",
    " major",
    " shift",
    " in",
    " how",
    " the",
    " industry",
    " believes",
    " drugs",
    " will",
    " be",
    " discovered",
    " in",
    " the",
    " future",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Advances",
    " in",
    " Therapeutics",
    " (",
    "Medicine",
    ")\n\n",
    "*",
    "  ",
    " **",
    "The",
    " Rise",
    " of",
    " G",
    "LP",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    " (",
    "Beyond",
    " Weight",
    " Loss",
    "):",
    "**",
    " While",
    " drugs",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "agl",
    "ut",
    "ide",
    ")",
    " and",
    " Z",
    "ep",
    "bound",
    " (",
    "t",
    "ir",
    "z",
    "epat",
    "ide",
    ")",
    " have",
    " dominated",
    " headlines",
    " for",
    " weight",
    " loss",
    ",",
    " recent",
    " research",
    " is",
    " revealing",
    " their",
    " potential",
    " in",
    " other",
    " areas",
    ".",
    " **",
    "New",
    " studies",
    " are",
    " showing",
    " significant",
    " benefits",
    " for",
    " heart",
    " health",
    ",",
    " kidney",
    " disease",
    ",",
    " and",
    " possibly",
    " even",
    " addiction",
    " and",
    " Alzheimer",
    "'s",
    ".**",
    " This",
    " expands",
    " their",
    " impact",
    " from",
    " metabolic",
    " health",
    " to",
    " much",
    " broader",
    " therapeutic",
    " applications",
    ".\n",
    "*",
    "  ",
    " **",
    "Personal",
    "ized",
    " Cancer",
    " Vacc",
    "ines",
    " Show",
    " Promise",
    ":**",
    " Building",
    " on",
    " the",
    " mRNA",
    " technology",
    " from",
    " COVID",
    "-",
    "19",
    " vaccines",
    ",",
    " companies",
    " like",
    " **",
    "Bio",
    "NT",
    "ech",
    " and",
    " Modern",
    "a",
    "**",
    " are",
    " making",
    " strides",
    " with",
    " personalized",
    " mRNA",
    " cancer",
    " vaccines",
    ".",
    " These",
    " vaccines",
    " are",
    " designed",
    " by",
    " sequencing",
    " a",
    " patient",
    "'s",
    " tumor",
    " to",
    " create",
    " a",
    " unique",
    " target",
    ",",
    " training",
    " the",
    " immune",
    " system",
    " to",
    " attack",
    " that",
    " specific",
    " cancer",
    ".",
    " Recent",
    " Phase",
    " II",
    " trials",
    " for",
    " melanoma",
    " have",
    " shown",
    " highly",
    " promising",
    " results",
    ",",
    " significantly",
    " reducing",
    " the",
    " risk",
    " of",
    " cancer",
    " recurrence",
    ".\n",
    "*",
    "  ",
    " **",
    "CR",
    "ISPR",
    " Therap",
    "ies",
    " Continue",
    " to",
    " Advance",
    ":**",
    " The",
    " first",
    " CRISPR",
    "-based",
    " gene",
    " therapies",
    " for",
    " sickle",
    " cell",
    " disease",
    " and",
    " beta",
    "-th",
    "al",
    "ass",
    "emia",
    " (",
    "Cas",
    "ge",
    "vy",
    ")",
    " were",
    " approved",
    " in",
    " the",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:40:56.783Z",
  "started_at": "2025-10-19T05:40:56.792123564Z",
  "completed_at": "2025-10-19T05:41:03.513415902Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/tbaawh9n9xrma0cszbybwjgqe0/cancel",
    "get": "https://api.replicate.com/v1/predictions/tbaawh9n9xrma0cszbybwjgqe0",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/zh4uajpbbap6z3je6w337qmcwlcwlin3tj75dfmu67x3s7pjmova",
    "web": "https://replicate.com/p/tbaawh9n9xrma0cszbybwjgqe0"
  },
  "metrics": {
    "predict_time": 6.721292342
  }
}
[2025-10-19 05:41:05 UTC] --- REQUEST END ---

[2025-10-19 05:41:05 UTC] --- REQUEST START ---
[2025-10-19 05:41:05 UTC] Flattened prompt text:
[2025-10-19 05:41:05 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening across medicine, sustainability, and fundamental research. Here are some of the most significant recent news stories and trends, broken down by category.

### 1. AI and Machine Learning Revolutionizing Discovery

This is arguably the biggest overarching trend, accelerating progress in all other areas.

*   **Google DeepMind's AlphaFold 3:** In a landmark paper published in *Nature* in May 2024, DeepMind unveiled AlphaFold 3. This is a massive leap from its predecessor. While AlphaFold 2 predicted protein structures with stunning accuracy, **AlphaFold 3 predicts the structure and interactions of nearly all of life's molecules**proteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylation).
    *   **Why it matters:** This allows researchers to model complete biological pathways and drug-target interactions with unprecedented precision, dramatically speeding up drug discovery and basic biological understanding.
*   **AI-Driven Drug Discovery:** Companies like **Isomorphic Labs** (an Alphabet spin-off from DeepMind) are now signing massive deals with pharma giants (e.g., Eli Lilly, Novartis) potentially worth over $1.5 billion to discover new therapeutics using their AI platforms. This signifies a major shift in how the industry believes drugs will be discovered in the future.

### 2. Advances in Therapeutics (Medicine)

*   **The Rise of GLP-1 Agonists (Beyond Weight Loss):** While drugs like Ozempic (semaglutide) and Zepbound (tirzepatide) have dominated headlines for weight loss, recent research is revealing their potential in other areas. **New studies are showing significant benefits for heart health, kidney disease, and possibly even addiction and Alzheimer's.** This expands their impact from metabolic health to much broader therapeutic applications.
*   **Personalized Cancer Vaccines Show Promise:** Building on the mRNA technology from COVID-19 vaccines, companies like **BioNTech and Moderna** are making strides with personalized mRNA cancer vaccines. These vaccines are designed by sequencing a patient's tumor to create a unique target, training the immune system to attack that specific cancer. Recent Phase II trials for melanoma have shown highly promising results, significantly reducing the risk of cancer recurrence.
*   **CRISPR Therapies Continue to Advance:** The first CRISPR-based gene therapies for sickle cell disease and beta-thalassemia (Casgevy) were approved in the


Please format this text block as markdown. Respond only with the markdown text result
Assistant:
[2025-10-19 05:41:05 UTC] JSON body:
[2025-10-19 05:41:05 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening across medicine, sustainability, and fundamental research. Here are some of the most significant recent news stories and trends, broken down by category.\n\n### 1. AI and Machine Learning Revolutionizing Discovery\n\nThis is arguably the biggest overarching trend, accelerating progress in all other areas.\n\n*   **Google DeepMind's AlphaFold 3:** In a landmark paper published in *Nature* in May 2024, DeepMind unveiled AlphaFold 3. This is a massive leap from its predecessor. While AlphaFold 2 predicted protein structures with stunning accuracy, **AlphaFold 3 predicts the structure and interactions of nearly all of life's molecules**\u2014proteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylation).\n    *   **Why it matters:** This allows researchers to model complete biological pathways and drug-target interactions with unprecedented precision, dramatically speeding up drug discovery and basic biological understanding.\n*   **AI-Driven Drug Discovery:** Companies like **Isomorphic Labs** (an Alphabet spin-off from DeepMind) are now signing massive deals with pharma giants (e.g., Eli Lilly, Novartis) potentially worth over $1.5 billion to discover new therapeutics using their AI platforms. This signifies a major shift in how the industry believes drugs will be discovered in the future.\n\n### 2. Advances in Therapeutics (Medicine)\n\n*   **The Rise of GLP-1 Agonists (Beyond Weight Loss):** While drugs like Ozempic (semaglutide) and Zepbound (tirzepatide) have dominated headlines for weight loss, recent research is revealing their potential in other areas. **New studies are showing significant benefits for heart health, kidney disease, and possibly even addiction and Alzheimer's.** This expands their impact from metabolic health to much broader therapeutic applications.\n*   **Personalized Cancer Vaccines Show Promise:** Building on the mRNA technology from COVID-19 vaccines, companies like **BioNTech and Moderna** are making strides with personalized mRNA cancer vaccines. These vaccines are designed by sequencing a patient's tumor to create a unique target, training the immune system to attack that specific cancer. Recent Phase II trials for melanoma have shown highly promising results, significantly reducing the risk of cancer recurrence.\n*   **CRISPR Therapies Continue to Advance:** The first CRISPR-based gene therapies for sickle cell disease and beta-thalassemia (Casgevy) were approved in the\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:41:09 UTC] Final status: succeeded
[2025-10-19 05:41:09 UTC] Final response JSON:
[2025-10-19 05:41:09 UTC] {
  "id": "svjgyx2pc1rm80cszby87rec7g",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening across medicine, sustainability, and fundamental research. Here are some of the most significant recent news stories and trends, broken down by category.\n\n### 1. AI and Machine Learning Revolutionizing Discovery\n\nThis is arguably the biggest overarching trend, accelerating progress in all other areas.\n\n*   **Google DeepMind's AlphaFold 3:** In a landmark paper published in *Nature* in May 2024, DeepMind unveiled AlphaFold 3. This is a massive leap from its predecessor. While AlphaFold 2 predicted protein structures with stunning accuracy, **AlphaFold 3 predicts the structure and interactions of nearly all of life's molecules**\u2014proteins, DNA, RNA, ligands, ions, and modified residues (like phosphorylation).\n    *   **Why it matters:** This allows researchers to model complete biological pathways and drug-target interactions with unprecedented precision, dramatically speeding up drug discovery and basic biological understanding.\n*   **AI-Driven Drug Discovery:** Companies like **Isomorphic Labs** (an Alphabet spin-off from DeepMind) are now signing massive deals with pharma giants (e.g., Eli Lilly, Novartis) potentially worth over $1.5 billion to discover new therapeutics using their AI platforms. This signifies a major shift in how the industry believes drugs will be discovered in the future.\n\n### 2. Advances in Therapeutics (Medicine)\n\n*   **The Rise of GLP-1 Agonists (Beyond Weight Loss):** While drugs like Ozempic (semaglutide) and Zepbound (tirzepatide) have dominated headlines for weight loss, recent research is revealing their potential in other areas. **New studies are showing significant benefits for heart health, kidney disease, and possibly even addiction and Alzheimer's.** This expands their impact from metabolic health to much broader therapeutic applications.\n*   **Personalized Cancer Vaccines Show Promise:** Building on the mRNA technology from COVID-19 vaccines, companies like **BioNTech and Moderna** are making strides with personalized mRNA cancer vaccines. These vaccines are designed by sequencing a patient's tumor to create a unique target, training the immune system to attack that specific cancer. Recent Phase II trials for melanoma have shown highly promising results, significantly reducing the risk of cancer recurrence.\n*   **CRISPR Therapies Continue to Advance:** The first CRISPR-based gene therapies for sickle cell disease and beta-thalassemia (Casgevy) were approved in the\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 625\nOutput token count: 510\nTotal token count: 1135\nTTFT: 0.36s\nFinish reason: stop\n",
  "output": [
    "",
    "``",
    "`\n",
    "Of",
    " course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " breakthroughs",
    " happening",
    " across",
    " medicine",
    ",",
    " sustainability",
    ",",
    " and",
    " fundamental",
    " research",
    ".",
    " Here",
    " are",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " stories",
    " and",
    " trends",
    ",",
    " broken",
    " down",
    " by",
    " category",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " Revolution",
    "izing",
    " Discovery",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " biggest",
    " overarching",
    " trend",
    ",",
    " accelerating",
    " progress",
    " in",
    " all",
    " other",
    " areas",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Google",
    " Deep",
    "Mind",
    "'s",
    " Alpha",
    "Fold",
    " ",
    "3",
    ":**",
    " In",
    " a",
    " landmark",
    " paper",
    " published",
    " in",
    " *",
    "Nature",
    "*",
    " in",
    " May",
    " ",
    "202",
    "4",
    ",",
    " Deep",
    "Mind",
    " unveiled",
    " Alpha",
    "Fold",
    " ",
    "3",
    ".",
    " This",
    " is",
    " a",
    " massive",
    " leap",
    " from",
    " its",
    " predecessor",
    ".",
    " While",
    " Alpha",
    "Fold",
    " ",
    "2",
    " predicted",
    " protein",
    " structures",
    " with",
    " stunning",
    " accuracy",
    ",",
    " **",
    "Alpha",
    "Fold",
    " ",
    "3",
    " predicts",
    " the",
    " structure",
    " and",
    " interactions",
    " of",
    " nearly",
    " all",
    " of",
    " life's",
    " molecules",
    "**",
    "\u2014",
    "prote",
    "ins",
    ",",
    " DNA",
    ",",
    " RNA",
    ",",
    " lig",
    "ands",
    ",",
    " ions",
    ",",
    " and",
    " modified",
    " residues",
    " (",
    "like",
    " phosphorylation",
    ").\n",
    "   ",
    " *",
    "  ",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " This",
    " allows",
    " researchers",
    " to",
    " model",
    " complete",
    " biological",
    " pathways",
    " and",
    " drug",
    "-target",
    " interactions",
    " with",
    " unprecedented",
    " precision",
    ",",
    " dramatically",
    " speeding",
    " up",
    " drug",
    " discovery",
    " and",
    " basic",
    " biological",
    " understanding",
    ".\n",
    "*",
    "  ",
    " **",
    "AI",
    "-",
    "Driven",
    " Drug",
    " Discovery",
    ":**",
    " Companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "an",
    " Alphabet",
    " spin",
    "-off",
    " from",
    " Deep",
    "Mind",
    ")",
    " are",
    " now",
    " signing",
    " massive",
    " deals",
    " with",
    " pharma",
    " giants",
    " (",
    "e",
    ".g",
    ".,",
    " Eli",
    " Lilly",
    ",",
    " Nov",
    "art",
    "is",
    ")",
    " potentially",
    " worth",
    " over",
    " $",
    "1",
    ".",
    "5",
    " billion",
    " to",
    " discover",
    " new",
    " therapeut",
    "ics",
    " using",
    " their",
    " AI",
    " platforms",
    ".",
    " This",
    " signifies",
    " a",
    " major",
    " shift",
    " in",
    " how",
    " the",
    " industry",
    " believes",
    " drugs",
    " will",
    " be",
    " discovered",
    " in",
    " the",
    " future",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " Advances",
    " in",
    " Therapeut",
    "ics",
    " (",
    "Medicine",
    ")\n\n",
    "*",
    "  ",
    " **",
    "The",
    " Rise",
    " of",
    " GL",
    "P",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    " (",
    "Beyond",
    " Weight",
    " Loss",
    "):",
    "**",
    " While",
    " drugs",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "ag",
    "lut",
    "ide",
    ")",
    " and",
    " Z",
    "ep",
    "bound",
    " (",
    "tir",
    "zep",
    "at",
    "ide",
    ")",
    " have",
    " dominated",
    " headlines",
    " for",
    " weight",
    " loss",
    ",",
    " recent",
    " research",
    " is",
    " revealing",
    " their",
    " potential",
    " in",
    " other",
    " areas",
    ".",
    " **",
    "New",
    " studies",
    " are",
    " showing",
    " significant",
    " benefits",
    " for",
    " heart",
    " health",
    ",",
    " kidney",
    " disease",
    ",",
    " and",
    " possibly",
    " even",
    " addiction",
    " and",
    " Alzheimer's",
    ".",
    "**",
    " This",
    " expands",
    " their",
    " impact",
    " from",
    " metabolic",
    " health",
    " to",
    " much",
    " broader",
    " therapeutic",
    " applications",
    ".\n",
    "*",
    "  ",
    " **",
    "Personal",
    "ized",
    " Cancer",
    " Vacc",
    "ines",
    " Show",
    " Promise",
    ":**",
    " Building",
    " on",
    " the",
    " m",
    "RNA",
    " technology",
    " from",
    " COVID",
    "-",
    "19",
    " vaccines",
    ",",
    " companies",
    " like",
    " **",
    "Bio",
    "N",
    "Tech",
    " and",
    " Moderna",
    "**",
    " are",
    " making",
    " strides",
    " with",
    " personalized",
    " m",
    "RNA",
    " cancer",
    " vaccines",
    ".",
    " These",
    " vaccines",
    " are",
    " designed",
    " by",
    " sequencing",
    " a",
    " patient's",
    " tumor",
    " to",
    " create",
    " a",
    " unique",
    " target",
    ",",
    " training",
    " the",
    " immune",
    " system",
    " to",
    " attack",
    " that",
    " specific",
    " cancer",
    ".",
    " Recent",
    " Phase",
    " II",
    " trials",
    " for",
    " melanoma",
    " have",
    " shown",
    " highly",
    " promising",
    " results",
    ",",
    " significantly",
    " reducing",
    " the",
    " risk",
    " of",
    " cancer",
    " recurrence",
    ".\n",
    "*",
    "  ",
    " **",
    "CR",
    "IS",
    "PR",
    " Therap",
    "ies",
    " Continue",
    " to",
    " Advance",
    ":**",
    " The",
    " first",
    " CR",
    "IS",
    "PR",
    "-based",
    " gene",
    " therapies",
    " for",
    " sick",
    "le",
    " cell",
    " disease",
    " and",
    " beta",
    "-th",
    "al",
    "assem",
    "ia",
    " (",
    "Cas",
    "ge",
    "vy",
    ")",
    " were",
    " approved",
    " in",
    " the",
    "\n",
    "``",
    "`\n"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:41:05.248Z",
  "started_at": "2025-10-19T05:41:05.251409494Z",
  "completed_at": "2025-10-19T05:41:08.06596866Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/svjgyx2pc1rm80cszby87rec7g/cancel",
    "get": "https://api.replicate.com/v1/predictions/svjgyx2pc1rm80cszby87rec7g",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/nccgdcfh3aliahwvjlqq3axnrsgxk3a3qlnx5zzkcvbv6cq5fppa",
    "web": "https://replicate.com/p/svjgyx2pc1rm80cszby87rec7g"
  },
  "metrics": {
    "input_token_count": 625,
    "output_token_count": 510,
    "predict_time": 2.814559166,
    "time_to_first_token": 0.101372188,
    "tokens_per_second": 187.97082697777861
  }
}
[2025-10-19 05:41:09 UTC] --- REQUEST END ---

[2025-10-19 05:43:06 UTC] --- REQUEST START ---
[2025-10-19 05:43:06 UTC] Prompt: research recent news in the biochemical space
[2025-10-19 05:43:06 UTC] Initial response JSON:
[2025-10-19 05:43:06 UTC] {
  "id": "1v5p87sgb1rm80cszbz9s86qvr",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:43:06.584Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/1v5p87sgb1rm80cszbz9s86qvr/cancel",
    "get": "https://api.replicate.com/v1/predictions/1v5p87sgb1rm80cszbz9s86qvr",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/eajd2iiganzxiweldvevqu5dl657cbtegy2fhhozp2zkvklrojgq",
    "web": "https://replicate.com/p/1v5p87sgb1rm80cszbz9s86qvr"
  }
}
[2025-10-19 05:43:12 UTC] Final status: succeeded
[2025-10-19 05:43:12 UTC] Final response JSON:
[2025-10-19 05:43:12 UTC] {
  "id": "1v5p87sgb1rm80cszbz9s86qvr",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the biochemical space\nInput token count: 7\nOutput token count: 517\nTTFT: 0.92s\nTokens per second: 83.42\nTotal time: 6.20s\n",
  "output": [
    "",
    "Of course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " breakthroughs",
    " happening",
    " weekly",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " significant",
    " recent",
    " news",
    " and",
    " trends",
    ",",
    " categorized",
    " for",
    " clarity",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " in",
    " Drug",
    " Discovery",
    " &",
    " Protein",
    " Design",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " most",
    " transformative",
    " trend",
    " in",
    " biochemistry",
    " right",
    " now",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Key",
    " News",
    ":**",
    " The",
    " dominance",
    " of",
    " AI",
    "-powered",
    " companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "a",
    " spin",
    "-off",
    " from",
    " Deep",
    "Mind",
    ")",
    " is",
    " making",
    " headlines",
    ".",
    " Recently",
    ",",
    " they",
    " signed",
    " massive",
    ",",
    " multi",
    "-b",
    "illion",
    " dollar",
    " partnerships",
    " with",
    " **",
    "E",
    "li",
    " Lilly",
    "**",
    " and",
    " **",
    "Nov",
    "art",
    "is",
    "**",
    " to",
    " apply",
    " their",
    " Alpha",
    "Fold",
    " technology",
    " to",
    " discover",
    " new",
    " therapeutic",
    " targets",
    " and",
    " drugs",
    ".\n",
    "*",
    "  ",
    " **",
    "Why",
    " it",
    "'s",
    " important",
    ":**",
    " Alpha",
    "Fold",
    " ",
    "2",
    " and",
    " ",
    "3",
    " (",
    "and",
    " competing",
    " models",
    " like",
    " E",
    "SM",
    "2",
    "/",
    "ES",
    "MF",
    "old",
    ")",
    " have",
    " revolutionized",
    " **",
    "protein",
    " structure",
    " prediction",
    "**.",
    " AI",
    " can",
    " now",
    " design",
    " novel",
    " proteins",
    " and",
    " enzymes",
    " (\"",
    "de",
    " novo",
    " design",
    "\")",
    " with",
    " specific",
    " functions",
    " far",
    " faster",
    " than",
    " traditional",
    " methods",
    ".",
    " This",
    " drastically",
    " accelerates",
    " the",
    " early",
    " stages",
    " of",
    " drug",
    " discovery",
    ",",
    " moving",
    " from",
    " target",
    " identification",
    " to",
    " lead",
    " compound",
    " optimization",
    " in",
    " months",
    " instead",
    " of",
    " years",
    ".\n",
    "*",
    "  ",
    " **",
    "Example",
    ":**",
    " Researchers",
    " are",
    " using",
    " AI",
    " to",
    " design",
    " new",
    " enzymes",
    " that",
    " can",
    " break",
    " down",
    " plastic",
    " waste",
    " (",
    "PET",
    "ase",
    ")",
    " or",
    " create",
    " new",
    " biom",
    "aterials",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " The",
    " Rise",
    " of",
    " G",
    "LP",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    " (",
    "Beyond",
    " Weight",
    " Loss",
    ")\n\n",
    "The",
    " success",
    " of",
    " drugs",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "agl",
    "ut",
    "ide",
    ")",
    " and",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "t",
    "ir",
    "z",
    "epat",
    "ide",
    ")",
    " continues",
    " to",
    " be",
    " a",
    " major",
    " story",
    ",",
    " with",
    " new",
    " biochemical",
    " insights",
    " emerging",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Key",
    " News",
    ":**",
    " Recent",
    " research",
    " is",
    " exploring",
    " the",
    " **",
    "ple",
    "iot",
    "ropic",
    " effects",
    "**",
    " of",
    " these",
    " drugs",
    "\u2014",
    "their",
    " impacts",
    " beyond",
    " glucose",
    " control",
    " and",
    " weight",
    " loss",
    ".",
    " Studies",
    " are",
    " investigating",
    " their",
    " potential",
    " benefits",
    " for",
    ":\n",
    "   ",
    " *",
    "  ",
    " **",
    "Card",
    "i",
    "ovascular",
    " Health",
    ":**",
    " Reducing",
    " the",
    " risk",
    " of",
    " heart",
    " attack",
    " and",
    " stroke",
    ",",
    " independent",
    " of",
    " weight",
    " loss",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Add",
    "iction",
    ":**",
    " Potential",
    " use",
    " in",
    " treating",
    " alcohol",
    " and",
    " substance",
    " use",
    " disorders",
    " by",
    " affecting",
    " reward",
    " pathways",
    " in",
    " the",
    " brain",
    ".\n",
    "   ",
    " *",
    "  ",
    " **",
    "Kid",
    "ney",
    " Disease",
    ":**",
    " Showing",
    " promise",
    " in",
    " slowing",
    " the",
    " progression",
    " of",
    " diabetic",
    " kidney",
    " disease",
    ".\n",
    "*",
    "  ",
    " **",
    "Why",
    " it",
    "'s",
    " important",
    ":**",
    " This",
    " expands",
    " the",
    " therapeutic",
    " and",
    " market",
    " potential",
    " of",
    " this",
    " drug",
    " class",
    " enormously",
    " and",
    " drives",
    " intense",
    " R",
    "&D",
    " into",
    " next",
    "-generation",
    ",",
    " even",
    " more",
    " effective",
    " multi",
    "-",
    "agon",
    "ists",
    ".\n\n",
    "###",
    " ",
    "3",
    ".",
    " Advances",
    " in",
    " CRISPR",
    " and",
    " Gene",
    " Editing",
    "\n\n",
    "CR",
    "ISPR",
    " technology",
    " is",
    " moving",
    " beyond",
    " simple",
    " gene",
    " cuts",
    " to",
    " more",
    " sophisticated",
    " editing",
    ".\n\n",
    "*",
    "  ",
    " **",
    "Key",
    " News",
    ":",
    "**\n",
    "   ",
    " *",
    "  ",
    " **",
    "First",
    " FDA",
    "-",
    "Appro",
    "ved",
    " CRISPR",
    " Therapy",
    ":**",
    " **",
    "Cas",
    "ge",
    "vy",
    "**",
    " (",
    "ex",
    "agam",
    "g",
    "log",
    "ene",
    " aut",
    "ot",
    "em",
    "cel",
    ")",
    " for",
    " sickle",
    " cell",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:43:06.584Z",
  "started_at": "2025-10-19T05:43:06.591959255Z",
  "completed_at": "2025-10-19T05:43:12.791238195Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/1v5p87sgb1rm80cszbz9s86qvr/cancel",
    "get": "https://api.replicate.com/v1/predictions/1v5p87sgb1rm80cszbz9s86qvr",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/eajd2iiganzxiweldvevqu5dl657cbtegy2fhhozp2zkvklrojgq",
    "web": "https://replicate.com/p/1v5p87sgb1rm80cszbz9s86qvr"
  },
  "metrics": {
    "predict_time": 6.199278936
  }
}
[2025-10-19 05:43:12 UTC] --- REQUEST END ---

[2025-10-19 05:43:12 UTC] --- REQUEST START ---
[2025-10-19 05:43:12 UTC] Flattened prompt text:
[2025-10-19 05:43:12 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.

### 1. AI and Machine Learning in Drug Discovery & Protein Design

This is arguably the most transformative trend in biochemistry right now.

*   **Key News:** The dominance of AI-powered companies like **Isomorphic Labs** (a spin-off from DeepMind) is making headlines. Recently, they signed massive, multi-billion dollar partnerships with **Eli Lilly** and **Novartis** to apply their AlphaFold technology to discover new therapeutic targets and drugs.
*   **Why it's important:** AlphaFold 2 and 3 (and competing models like ESM2/ESMFold) have revolutionized **protein structure prediction**. AI can now design novel proteins and enzymes ("de novo design") with specific functions far faster than traditional methods. This drastically accelerates the early stages of drug discovery, moving from target identification to lead compound optimization in months instead of years.
*   **Example:** Researchers are using AI to design new enzymes that can break down plastic waste (PETase) or create new biomaterials.

### 2. The Rise of GLP-1 Agonists (Beyond Weight Loss)

The success of drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to be a major story, with new biochemical insights emerging.

*   **Key News:** Recent research is exploring the **pleiotropic effects** of these drugstheir impacts beyond glucose control and weight loss. Studies are investigating their potential benefits for:
    *   **Cardiovascular Health:** Reducing the risk of heart attack and stroke, independent of weight loss.
    *   **Addiction:** Potential use in treating alcohol and substance use disorders by affecting reward pathways in the brain.
    *   **Kidney Disease:** Showing promise in slowing the progression of diabetic kidney disease.
*   **Why it's important:** This expands the therapeutic and market potential of this drug class enormously and drives intense R&D into next-generation, even more effective multi-agonists.

### 3. Advances in CRISPR and Gene Editing

CRISPR technology is moving beyond simple gene cuts to more sophisticated editing.

*   **Key News:**
    *   **First FDA-Approved CRISPR Therapy:** **Casgevy** (exagamglogene autotemcel) for sickle cell


Please format this text block as markdown. Respond only with the markdown text result
Assistant:
[2025-10-19 05:43:12 UTC] JSON body:
[2025-10-19 05:43:12 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.\n\n### 1. AI and Machine Learning in Drug Discovery & Protein Design\n\nThis is arguably the most transformative trend in biochemistry right now.\n\n*   **Key News:** The dominance of AI-powered companies like **Isomorphic Labs** (a spin-off from DeepMind) is making headlines. Recently, they signed massive, multi-billion dollar partnerships with **Eli Lilly** and **Novartis** to apply their AlphaFold technology to discover new therapeutic targets and drugs.\n*   **Why it's important:** AlphaFold 2 and 3 (and competing models like ESM2/ESMFold) have revolutionized **protein structure prediction**. AI can now design novel proteins and enzymes (\"de novo design\") with specific functions far faster than traditional methods. This drastically accelerates the early stages of drug discovery, moving from target identification to lead compound optimization in months instead of years.\n*   **Example:** Researchers are using AI to design new enzymes that can break down plastic waste (PETase) or create new biomaterials.\n\n### 2. The Rise of GLP-1 Agonists (Beyond Weight Loss)\n\nThe success of drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to be a major story, with new biochemical insights emerging.\n\n*   **Key News:** Recent research is exploring the **pleiotropic effects** of these drugs\u2014their impacts beyond glucose control and weight loss. Studies are investigating their potential benefits for:\n    *   **Cardiovascular Health:** Reducing the risk of heart attack and stroke, independent of weight loss.\n    *   **Addiction:** Potential use in treating alcohol and substance use disorders by affecting reward pathways in the brain.\n    *   **Kidney Disease:** Showing promise in slowing the progression of diabetic kidney disease.\n*   **Why it's important:** This expands the therapeutic and market potential of this drug class enormously and drives intense R&D into next-generation, even more effective multi-agonists.\n\n### 3. Advances in CRISPR and Gene Editing\n\nCRISPR technology is moving beyond simple gene cuts to more sophisticated editing.\n\n*   **Key News:**\n    *   **First FDA-Approved CRISPR Therapy:** **Casgevy** (exagamglogene autotemcel) for sickle cell\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:43:17 UTC] Final status: succeeded
[2025-10-19 05:43:17 UTC] Final response JSON:
[2025-10-19 05:43:17 UTC] {
  "id": "592szpj9mxrme0cszbzapsf8xm",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with breakthroughs happening weekly. Here is a summary of some of the most significant recent news and trends, categorized for clarity.\n\n### 1. AI and Machine Learning in Drug Discovery & Protein Design\n\nThis is arguably the most transformative trend in biochemistry right now.\n\n*   **Key News:** The dominance of AI-powered companies like **Isomorphic Labs** (a spin-off from DeepMind) is making headlines. Recently, they signed massive, multi-billion dollar partnerships with **Eli Lilly** and **Novartis** to apply their AlphaFold technology to discover new therapeutic targets and drugs.\n*   **Why it's important:** AlphaFold 2 and 3 (and competing models like ESM2/ESMFold) have revolutionized **protein structure prediction**. AI can now design novel proteins and enzymes (\"de novo design\") with specific functions far faster than traditional methods. This drastically accelerates the early stages of drug discovery, moving from target identification to lead compound optimization in months instead of years.\n*   **Example:** Researchers are using AI to design new enzymes that can break down plastic waste (PETase) or create new biomaterials.\n\n### 2. The Rise of GLP-1 Agonists (Beyond Weight Loss)\n\nThe success of drugs like Ozempic (semaglutide) and Mounjaro (tirzepatide) continues to be a major story, with new biochemical insights emerging.\n\n*   **Key News:** Recent research is exploring the **pleiotropic effects** of these drugs\u2014their impacts beyond glucose control and weight loss. Studies are investigating their potential benefits for:\n    *   **Cardiovascular Health:** Reducing the risk of heart attack and stroke, independent of weight loss.\n    *   **Addiction:** Potential use in treating alcohol and substance use disorders by affecting reward pathways in the brain.\n    *   **Kidney Disease:** Showing promise in slowing the progression of diabetic kidney disease.\n*   **Why it's important:** This expands the therapeutic and market potential of this drug class enormously and drives intense R&D into next-generation, even more effective multi-agonists.\n\n### 3. Advances in CRISPR and Gene Editing\n\nCRISPR technology is moving beyond simple gene cuts to more sophisticated editing.\n\n*   **Key News:**\n    *   **First FDA-Approved CRISPR Therapy:** **Casgevy** (exagamglogene autotemcel) for sickle cell\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 625\nOutput token count: 461\nTotal token count: 1086\nTTFT: 0.91s\nFinish reason: stop\n",
  "output": [
    "",
    "###",
    " ",
    "1",
    ".",
    " AI",
    " and",
    " Machine",
    " Learning",
    " in",
    " Drug",
    " Discovery",
    " &",
    " Protein",
    " Design",
    "\n\n",
    "This",
    " is",
    " arguably",
    " the",
    " most",
    " transformative",
    " trend",
    " in",
    " bi",
    "ochemistry",
    " right",
    " now",
    ".\n\n",
    "-",
    " **",
    "Key",
    " News",
    ":**",
    " The",
    " dominance",
    " of",
    " AI",
    "-powered",
    " companies",
    " like",
    " **",
    "Is",
    "omorphic",
    " Labs",
    "**",
    " (",
    "a",
    " spin",
    "-off",
    " from",
    " Deep",
    "Mind",
    ")",
    " is",
    " making",
    " headlines",
    ".",
    " Recently",
    ",",
    " they",
    " signed",
    " massive",
    ",",
    " multi",
    "-billion",
    " dollar",
    " partnerships",
    " with",
    " **",
    "E",
    "li",
    " Lilly",
    "**",
    " and",
    " **",
    "Nov",
    "art",
    "is",
    "**",
    " to",
    " apply",
    " their",
    " Alpha",
    "Fold",
    " technology",
    " to",
    " discover",
    " new",
    " therapeutic",
    " targets",
    " and",
    " drugs",
    ".\n",
    "-",
    " **",
    "Why",
    " it's",
    " important",
    ":**",
    " Alpha",
    "Fold",
    " ",
    "2",
    " and",
    " ",
    "3",
    " (",
    "and",
    " competing",
    " models",
    " like",
    " E",
    "SM",
    "2",
    "/",
    "ES",
    "MF",
    "old",
    ")",
    " have",
    " revolution",
    "ized",
    " **",
    "protein",
    " structure",
    " prediction",
    "**",
    ".",
    " AI",
    " can",
    " now",
    " design",
    " novel",
    " proteins",
    " and",
    " enzymes",
    " (\"",
    "de",
    " novo",
    " design",
    "\")",
    " with",
    " specific",
    " functions",
    " far",
    " faster",
    " than",
    " traditional",
    " methods",
    ".",
    " This",
    " drastically",
    " acceler",
    "ates",
    " the",
    " early",
    " stages",
    " of",
    " drug",
    " discovery",
    ",",
    " moving",
    " from",
    " target",
    " identification",
    " to",
    " lead",
    " compound",
    " optimization",
    " in",
    " months",
    " instead",
    " of",
    " years",
    ".\n",
    "-",
    " **",
    "Example",
    ":**",
    " Researchers",
    " are",
    " using",
    " AI",
    " to",
    " design",
    " new",
    " enzymes",
    " that",
    " can",
    " break",
    " down",
    " plastic",
    " waste",
    " (",
    "PET",
    "ase",
    ")",
    " or",
    " create",
    " new",
    " biom",
    "aterials",
    ".\n\n",
    "###",
    " ",
    "2",
    ".",
    " The",
    " Rise",
    " of",
    " GL",
    "P",
    "-",
    "1",
    " Ag",
    "on",
    "ists",
    " (",
    "Beyond",
    " Weight",
    " Loss",
    ")\n\n",
    "The",
    " success",
    " of",
    " drugs",
    " like",
    " Oz",
    "emp",
    "ic",
    " (",
    "sem",
    "ag",
    "lut",
    "ide",
    ")",
    " and",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "tir",
    "zep",
    "at",
    "ide",
    ")",
    " continues",
    " to",
    " be",
    " a",
    " major",
    " story",
    ",",
    " with",
    " new",
    " biochemical",
    " insights",
    " emerging",
    ".\n\n",
    "-",
    " **",
    "Key",
    " News",
    ":**",
    " Recent",
    " research",
    " is",
    " exploring",
    " the",
    " **",
    "ple",
    "iot",
    "ropic",
    " effects",
    "**",
    " of",
    " these",
    " drugs",
    "\u2014the",
    "ir",
    " impacts",
    " beyond",
    " glucose",
    " control",
    " and",
    " weight",
    " loss",
    ".",
    " Studies",
    " are",
    " investigating",
    " their",
    " potential",
    " benefits",
    " for",
    ":\n",
    " ",
    " -",
    " **",
    "Card",
    "i",
    "ovascular",
    " Health",
    ":**",
    " Red",
    "ucing",
    " the",
    " risk",
    " of",
    " heart",
    " attack",
    " and",
    " stroke",
    ",",
    " independent",
    " of",
    " weight",
    " loss",
    ".\n",
    " ",
    " -",
    " **",
    "Add",
    "iction",
    ":**",
    " Potential",
    " use",
    " in",
    " treating",
    " alcohol",
    " and",
    " substance",
    " use",
    " disorders",
    " by",
    " affecting",
    " reward",
    " pathways",
    " in",
    " the",
    " brain",
    ".\n",
    " ",
    " -",
    " **",
    "Kid",
    "ney",
    " Disease",
    ":**",
    " Showing",
    " promise",
    " in",
    " slowing",
    " the",
    " progression",
    " of",
    " diabetic",
    " kidney",
    " disease",
    ".\n",
    "-",
    " **",
    "Why",
    " it's",
    " important",
    ":**",
    " This",
    " expands",
    " the",
    " therapeutic",
    " and",
    " market",
    " potential",
    " of",
    " this",
    " drug",
    " class",
    " enormously",
    " and",
    " drives",
    " intense",
    " R",
    "&D",
    " into",
    " next",
    "-generation",
    ",",
    " even",
    " more",
    " effective",
    " multi",
    "-",
    "agon",
    "ists",
    ".\n\n",
    "###",
    " ",
    "3",
    ".",
    " Advances",
    " in",
    " CR",
    "IS",
    "PR",
    " and",
    " Gene",
    " Editing",
    "\n\n",
    "CR",
    "IS",
    "PR",
    " technology",
    " is",
    " moving",
    " beyond",
    " simple",
    " gene",
    " cuts",
    " to",
    " more",
    " sophisticated",
    " editing",
    ".\n\n",
    "-",
    " **",
    "Key",
    " News",
    ":",
    "**\n",
    " ",
    " -",
    " **",
    "First",
    " FDA",
    "-",
    "Approved",
    " CR",
    "IS",
    "PR",
    " Therapy",
    ":**",
    " **",
    "Cas",
    "ge",
    "vy",
    "**",
    " (",
    "ex",
    "agam",
    "g",
    "log",
    "ene",
    " autot",
    "em",
    "cel",
    ")",
    " for",
    " sick",
    "le",
    " cell"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:43:13.063Z",
  "started_at": "2025-10-19T05:43:13.066345359Z",
  "completed_at": "2025-10-19T05:43:15.659490031Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/592szpj9mxrme0cszbzapsf8xm/cancel",
    "get": "https://api.replicate.com/v1/predictions/592szpj9mxrme0cszbzapsf8xm",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/hgk2pvemnpwz3qtb2w6hhngq7tzxnoce3jb7kgzgyztx74e43y2q",
    "web": "https://replicate.com/p/592szpj9mxrme0cszbzapsf8xm"
  },
  "metrics": {
    "input_token_count": 625,
    "output_token_count": 461,
    "predict_time": 2.593144671,
    "time_to_first_token": 0.076135271,
    "tokens_per_second": 183.15386505906574
  }
}
[2025-10-19 05:43:17 UTC] --- REQUEST END ---

[2025-10-19 05:43:52 UTC] --- REQUEST START ---
[2025-10-19 05:43:52 UTC] Prompt: research recent news in the biochemical space
[2025-10-19 05:43:52 UTC] Initial response JSON:
[2025-10-19 05:43:52 UTC] {
  "id": "31gzf1f33nrma0cszbz8945v5g",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "",
  "output": null,
  "data_removed": false,
  "error": null,
  "status": "starting",
  "created_at": "2025-10-19T05:43:52.349Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/31gzf1f33nrma0cszbz8945v5g/cancel",
    "get": "https://api.replicate.com/v1/predictions/31gzf1f33nrma0cszbz8945v5g",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/begzdlj44km7tez62gsyhk6rq3obwpgjjf4rztostc5wmbjok5yq",
    "web": "https://replicate.com/p/31gzf1f33nrma0cszbz8945v5g"
  }
}
[2025-10-19 05:44:02 UTC] Final status: succeeded
[2025-10-19 05:44:02 UTC] Final response JSON:
[2025-10-19 05:44:02 UTC] {
  "id": "31gzf1f33nrma0cszbz8945v5g",
  "model": "deepseek-ai/deepseek-v3.1",
  "version": "hidden",
  "input": {
    "max_tokens": 500,
    "prompt": "research recent news in the biochemical space",
    "temperature": 0.7
  },
  "logs": "Prompt: research recent news in the biochemical space\nInput token count: 7\nOutput token count: 526\nTTFT: 1.43s\nTokens per second: 53.15\nTotal time: 9.90s\n",
  "output": [
    "",
    "Of course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " significant",
    " news",
    " spanning",
    " therapeutics",
    ",",
    " research",
    " breakthroughs",
    ",",
    " and",
    " industry",
    " trends",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " impactful",
    " recent",
    " developments",
    ",",
    " categorized",
    " for",
    " clarity",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " Therapeutics",
    " and",
    " Medicine",
    "\n\n",
    "This",
    " area",
    " continues",
    " to",
    " see",
    " the",
    " most",
    " dramatic",
    " progress",
    ",",
    " particularly",
    " in",
    " oncology",
    ",",
    " metabolic",
    " diseases",
    ",",
    " and",
    " neu",
    "rology",
    ".\n\n",
    "**",
    "A",
    ".",
    " Cancer",
    ":",
    " The",
    " Rise",
    " of",
    " \"",
    "ADC",
    "\"",
    " Drugs",
    "**\n",
    "Ant",
    "ib",
    "ody",
    "-D",
    "rug",
    " Con",
    "jug",
    "ates",
    " (",
    "AD",
    "Cs",
    ")",
    " are",
    " a",
    " hot",
    " topic",
    ".",
    " They",
    " are",
    " targeted",
    " therapies",
    " consisting",
    " of",
    " a",
    " monoclonal",
    " antibody",
    " linked",
    " to",
    " a",
    " potent",
    " cytotoxic",
    " drug",
    ".",
    " The",
    " antibody",
    " seeks",
    " out",
    " cancer",
    "-specific",
    " antigens",
    ",",
    " delivering",
    " the",
    " chemo",
    " payload",
    " directly",
    " to",
    " the",
    " tumor",
    " cell",
    ",",
    " minimizing",
    " damage",
    " to",
    " healthy",
    " cells",
    ".\n",
    "*",
    "  ",
    " **",
    "Recent",
    " News",
    ":**",
    " The",
    " market",
    " is",
    " booming",
    " with",
    " major",
    " acquisitions",
    ".",
    " **",
    "A",
    "stra",
    "Zen",
    "eca",
    "'s",
    "**",
    " deal",
    " to",
    " acquire",
    " **",
    "Da",
    "ichi",
    " Sank",
    "yo",
    "'s",
    "**",
    " cancer",
    " ADC",
    " portfolio",
    " for",
    " up",
    " to",
    " $",
    "6",
    " billion",
    " is",
    " a",
    " prime",
    " example",
    ".",
    " Similarly",
    ",",
    " **",
    "Mer",
    "ck",
    " &",
    " Co",
    ".**",
    " (",
    "known",
    " as",
    " MS",
    "D",
    " outside",
    " North",
    " America",
    ")",
    " signed",
    " a",
    " multi",
    "-b",
    "illion",
    " dollar",
    " deal",
    " with",
    " **",
    "D",
    "ai",
    "ichi",
    " Sank",
    "yo",
    "**",
    " for",
    " three",
    " of",
    " their",
    " AD",
    "Cs",
    ".",
    " This",
    " signifies",
    " a",
    " massive",
    " bet",
    " by",
    " big",
    " ph",
    "arma",
    " on",
    " this",
    " technology",
    ".\n",
    "*",
    "  ",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " AD",
    "Cs",
    " represent",
    " a",
    " more",
    " precise",
    " and",
    " potent",
    " form",
    " of",
    " chemotherapy",
    ",",
    " offering",
    " new",
    " hope",
    " for",
    " patients",
    " with",
    " hard",
    "-to",
    "-t",
    "reat",
    " cancers",
    ".\n\n",
    "**",
    "B",
    ".",
    " Obesity",
    " and",
    " Metabolic",
    " Disease",
    ":",
    " Beyond",
    " G",
    "LP",
    "-",
    "1",
    "**\n",
    "While",
    " G",
    "LP",
    "-",
    "1",
    " agonists",
    " like",
    " Oz",
    "emp",
    "ic",
    " and",
    " Weg",
    "ovy",
    " (",
    "sem",
    "agl",
    "ut",
    "ide",
    ")",
    " dominate",
    " headlines",
    ",",
    " the",
    " next",
    " generation",
    " of",
    " weight",
    "-loss",
    " drugs",
    " is",
    " already",
    " in",
    " development",
    ".\n",
    "*",
    "  ",
    " **",
    "Recent",
    " News",
    ":**",
    " Companies",
    " are",
    " developing",
    " dual",
    "-",
    " and",
    " even",
    " triple",
    "-",
    "agonist",
    " drugs",
    " that",
    " target",
    " multiple",
    " metabolic",
    " pathways",
    " simultaneously",
    " (",
    "e",
    ".g",
    ".,",
    " G",
    "LP",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " gluc",
    "agon",
    ").",
    " **",
    "E",
    "li",
    " Lilly",
    "'s",
    "**",
    " ret",
    "at",
    "rut",
    "ide",
    " (",
    "target",
    "ing",
    " G",
    "LP",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " and",
    " gluc",
    "agon",
    " receptors",
    ")",
    " has",
    " shown",
    " remarkable",
    " efficacy",
    " in",
    " trials",
    ",",
    " surpassing",
    " even",
    " their",
    " block",
    "buster",
    " drug",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "t",
    "ir",
    "z",
    "epat",
    "ide",
    ").",
    " **",
    "Am",
    "gen",
    "**",
    " is",
    " also",
    " advancing",
    " its",
    " experimental",
    " candidate",
    ",",
    " Mari",
    "T",
    "ide",
    " (",
    "AM",
    "G",
    " ",
    "133",
    "),",
    " which",
    " uses",
    " a",
    " different",
    " mechanism",
    ".\n",
    "*",
    "  ",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " This",
    " R",
    "&D",
    " race",
    " aims",
    " to",
    " create",
    " more",
    " effective",
    " treatments",
    " with",
    " potentially",
    " fewer",
    " side",
    " effects",
    ",",
    " moving",
    " from",
    " managing",
    " weight",
    " to",
    " potentially",
    " curing",
    " obesity",
    "-related",
    " comorbidities",
    ".\n\n",
    "**",
    "C",
    ".",
    " Neurology",
    ":",
    " Progress",
    " in",
    " Alzheimer",
    "'s",
    " Disease",
    "**\n",
    "The",
    " focus",
    " has",
    " shifted",
    " from",
    " targeting",
    " amyloid",
    " plaques",
    " alone",
    " to",
    " addressing",
    " other",
    " pathological",
    " drivers",
    " like",
    " tau",
    " protein",
    " and",
    " neuro",
    "in",
    "flammation",
    ".\n",
    "*",
    "  ",
    " **",
    "Recent",
    ""
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:43:52.349Z",
  "started_at": "2025-10-19T05:43:52.36159059Z",
  "completed_at": "2025-10-19T05:44:02.259570317Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/31gzf1f33nrma0cszbz8945v5g/cancel",
    "get": "https://api.replicate.com/v1/predictions/31gzf1f33nrma0cszbz8945v5g",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/begzdlj44km7tez62gsyhk6rq3obwpgjjf4rztostc5wmbjok5yq",
    "web": "https://replicate.com/p/31gzf1f33nrma0cszbz8945v5g"
  },
  "metrics": {
    "predict_time": 9.897979724
  }
}
[2025-10-19 05:44:02 UTC] --- REQUEST END ---

[2025-10-19 05:44:02 UTC] --- REQUEST START ---
[2025-10-19 05:44:02 UTC] Flattened prompt text:
[2025-10-19 05:44:02 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: Of course. The biochemical space is incredibly dynamic, with significant news spanning therapeutics, research breakthroughs, and industry trends. Here is a summary of some of the most impactful recent developments, categorized for clarity.

### 1. Therapeutics and Medicine

This area continues to see the most dramatic progress, particularly in oncology, metabolic diseases, and neurology.

**A. Cancer: The Rise of "ADC" Drugs**
Antibody-Drug Conjugates (ADCs) are a hot topic. They are targeted therapies consisting of a monoclonal antibody linked to a potent cytotoxic drug. The antibody seeks out cancer-specific antigens, delivering the chemo payload directly to the tumor cell, minimizing damage to healthy cells.
*   **Recent News:** The market is booming with major acquisitions. **AstraZeneca's** deal to acquire **Daichi Sankyo's** cancer ADC portfolio for up to $6 billion is a prime example. Similarly, **Merck & Co.** (known as MSD outside North America) signed a multi-billion dollar deal with **Daiichi Sankyo** for three of their ADCs. This signifies a massive bet by big pharma on this technology.
*   **Why it matters:** ADCs represent a more precise and potent form of chemotherapy, offering new hope for patients with hard-to-treat cancers.

**B. Obesity and Metabolic Disease: Beyond GLP-1**
While GLP-1 agonists like Ozempic and Wegovy (semaglutide) dominate headlines, the next generation of weight-loss drugs is already in development.
*   **Recent News:** Companies are developing dual- and even triple-agonist drugs that target multiple metabolic pathways simultaneously (e.g., GLP-1, GIP, glucagon). **Eli Lilly's** retatrutide (targeting GLP-1, GIP, and glucagon receptors) has shown remarkable efficacy in trials, surpassing even their blockbuster drug Mounjaro (tirzepatide). **Amgen** is also advancing its experimental candidate, MariTide (AMG 133), which uses a different mechanism.
*   **Why it matters:** This R&D race aims to create more effective treatments with potentially fewer side effects, moving from managing weight to potentially curing obesity-related comorbidities.

**C. Neurology: Progress in Alzheimer's Disease**
The focus has shifted from targeting amyloid plaques alone to addressing other pathological drivers like tau protein and neuroinflammation.
*   **Recent


Please format this text block as markdown. Respond only with the markdown text result
Assistant:
[2025-10-19 05:44:02 UTC] JSON body:
[2025-10-19 05:44:02 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with significant news spanning therapeutics, research breakthroughs, and industry trends. Here is a summary of some of the most impactful recent developments, categorized for clarity.\n\n### 1. Therapeutics and Medicine\n\nThis area continues to see the most dramatic progress, particularly in oncology, metabolic diseases, and neurology.\n\n**A. Cancer: The Rise of \"ADC\" Drugs**\nAntibody-Drug Conjugates (ADCs) are a hot topic. They are targeted therapies consisting of a monoclonal antibody linked to a potent cytotoxic drug. The antibody seeks out cancer-specific antigens, delivering the chemo payload directly to the tumor cell, minimizing damage to healthy cells.\n*   **Recent News:** The market is booming with major acquisitions. **AstraZeneca's** deal to acquire **Daichi Sankyo's** cancer ADC portfolio for up to $6 billion is a prime example. Similarly, **Merck & Co.** (known as MSD outside North America) signed a multi-billion dollar deal with **Daiichi Sankyo** for three of their ADCs. This signifies a massive bet by big pharma on this technology.\n*   **Why it matters:** ADCs represent a more precise and potent form of chemotherapy, offering new hope for patients with hard-to-treat cancers.\n\n**B. Obesity and Metabolic Disease: Beyond GLP-1**\nWhile GLP-1 agonists like Ozempic and Wegovy (semaglutide) dominate headlines, the next generation of weight-loss drugs is already in development.\n*   **Recent News:** Companies are developing dual- and even triple-agonist drugs that target multiple metabolic pathways simultaneously (e.g., GLP-1, GIP, glucagon). **Eli Lilly's** retatrutide (targeting GLP-1, GIP, and glucagon receptors) has shown remarkable efficacy in trials, surpassing even their blockbuster drug Mounjaro (tirzepatide). **Amgen** is also advancing its experimental candidate, MariTide (AMG 133), which uses a different mechanism.\n*   **Why it matters:** This R&D race aims to create more effective treatments with potentially fewer side effects, moving from managing weight to potentially curing obesity-related comorbidities.\n\n**C. Neurology: Progress in Alzheimer's Disease**\nThe focus has shifted from targeting amyloid plaques alone to addressing other pathological drivers like tau protein and neuroinflammation.\n*   **Recent\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:44:07 UTC] Final status: succeeded
[2025-10-19 05:44:07 UTC] Final response JSON:
[2025-10-19 05:44:07 UTC] {
  "id": "841thdgc9drma0cszbzrf0t1yc",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: Of course. The biochemical space is incredibly dynamic, with significant news spanning therapeutics, research breakthroughs, and industry trends. Here is a summary of some of the most impactful recent developments, categorized for clarity.\n\n### 1. Therapeutics and Medicine\n\nThis area continues to see the most dramatic progress, particularly in oncology, metabolic diseases, and neurology.\n\n**A. Cancer: The Rise of \"ADC\" Drugs**\nAntibody-Drug Conjugates (ADCs) are a hot topic. They are targeted therapies consisting of a monoclonal antibody linked to a potent cytotoxic drug. The antibody seeks out cancer-specific antigens, delivering the chemo payload directly to the tumor cell, minimizing damage to healthy cells.\n*   **Recent News:** The market is booming with major acquisitions. **AstraZeneca's** deal to acquire **Daichi Sankyo's** cancer ADC portfolio for up to $6 billion is a prime example. Similarly, **Merck & Co.** (known as MSD outside North America) signed a multi-billion dollar deal with **Daiichi Sankyo** for three of their ADCs. This signifies a massive bet by big pharma on this technology.\n*   **Why it matters:** ADCs represent a more precise and potent form of chemotherapy, offering new hope for patients with hard-to-treat cancers.\n\n**B. Obesity and Metabolic Disease: Beyond GLP-1**\nWhile GLP-1 agonists like Ozempic and Wegovy (semaglutide) dominate headlines, the next generation of weight-loss drugs is already in development.\n*   **Recent News:** Companies are developing dual- and even triple-agonist drugs that target multiple metabolic pathways simultaneously (e.g., GLP-1, GIP, glucagon). **Eli Lilly's** retatrutide (targeting GLP-1, GIP, and glucagon receptors) has shown remarkable efficacy in trials, surpassing even their blockbuster drug Mounjaro (tirzepatide). **Amgen** is also advancing its experimental candidate, MariTide (AMG 133), which uses a different mechanism.\n*   **Why it matters:** This R&D race aims to create more effective treatments with potentially fewer side effects, moving from managing weight to potentially curing obesity-related comorbidities.\n\n**C. Neurology: Progress in Alzheimer's Disease**\nThe focus has shifted from targeting amyloid plaques alone to addressing other pathological drivers like tau protein and neuroinflammation.\n*   **Recent\n\n\nPlease format this text block as markdown. Respond only with the markdown text result\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 629\nOutput token count: 508\nTotal token count: 1137\nTTFT: 0.44s\nFinish reason: stop\n",
  "output": [
    "",
    "``",
    "`\n",
    "Of",
    " course",
    ".",
    " The",
    " biochemical",
    " space",
    " is",
    " incredibly",
    " dynamic",
    ",",
    " with",
    " significant",
    " news",
    " spanning",
    " therapeut",
    "ics",
    ",",
    " research",
    " breakthroughs",
    ",",
    " and",
    " industry",
    " trends",
    ".",
    " Here",
    " is",
    " a",
    " summary",
    " of",
    " some",
    " of",
    " the",
    " most",
    " impactful",
    " recent",
    " developments",
    ",",
    " categorized",
    " for",
    " clarity",
    ".\n\n",
    "###",
    " ",
    "1",
    ".",
    " Therapeut",
    "ics",
    " and",
    " Medicine",
    "\n\n",
    "This",
    " area",
    " continues",
    " to",
    " see",
    " the",
    " most",
    " dramatic",
    " progress",
    ",",
    " particularly",
    " in",
    " oncology",
    ",",
    " metabolic",
    " diseases",
    ",",
    " and",
    " neu",
    "rology",
    ".\n\n",
    "**",
    "A",
    ".",
    " Cancer",
    ":",
    " The",
    " Rise",
    " of",
    " \"",
    "ADC",
    "\"",
    " Drugs",
    "**",
    "  \n",
    "Ant",
    "ibody",
    "-",
    "Drug",
    " Con",
    "jug",
    "ates",
    " (",
    "AD",
    "Cs",
    ")",
    " are",
    " a",
    " hot",
    " topic",
    ".",
    " They",
    " are",
    " targeted",
    " therapies",
    " consisting",
    " of",
    " a",
    " monoc",
    "lon",
    "al",
    " antibody",
    " linked",
    " to",
    " a",
    " potent",
    " cyt",
    "otoxic",
    " drug",
    ".",
    " The",
    " antibody",
    " seeks",
    " out",
    " cancer",
    "-specific",
    " ant",
    "igens",
    ",",
    " delivering",
    " the",
    " chemo",
    " payload",
    " directly",
    " to",
    " the",
    " tumor",
    " cell",
    ",",
    " minimizing",
    " damage",
    " to",
    " healthy",
    " cells",
    ".\n\n",
    "*",
    " **",
    "Recent",
    " News",
    ":**",
    " The",
    " market",
    " is",
    " booming",
    " with",
    " major",
    " acquisitions",
    ".",
    " **",
    "A",
    "stra",
    "Zeneca",
    "'s",
    "**",
    " deal",
    " to",
    " acquire",
    " **",
    "Da",
    "ichi",
    " Sank",
    "yo",
    "'s",
    "**",
    " cancer",
    " ADC",
    " portfolio",
    " for",
    " up",
    " to",
    " $",
    "6",
    " billion",
    " is",
    " a",
    " prime",
    " example",
    ".",
    " Similarly",
    ",",
    " **",
    "Mer",
    "ck",
    " &",
    " Co",
    ".",
    "**",
    " (",
    "known",
    " as",
    " MSD",
    " outside",
    " North",
    " America",
    ")",
    " signed",
    " a",
    " multi",
    "-billion",
    " dollar",
    " deal",
    " with",
    " **",
    "D",
    "ai",
    "ichi",
    " Sank",
    "yo",
    "**",
    " for",
    " three",
    " of",
    " their",
    " ADC",
    "s",
    ".",
    " This",
    " signifies",
    " a",
    " massive",
    " bet",
    " by",
    " big",
    " pharma",
    " on",
    " this",
    " technology",
    ".\n",
    "*",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " ADC",
    "s",
    " represent",
    " a",
    " more",
    " precise",
    " and",
    " potent",
    " form",
    " of",
    " chemotherapy",
    ",",
    " offering",
    " new",
    " hope",
    " for",
    " patients",
    " with",
    " hard",
    "-to",
    "-t",
    "reat",
    " cancers",
    ".\n\n",
    "**",
    "B",
    ".",
    " Ob",
    "esity",
    " and",
    " Met",
    "abolic",
    " Disease",
    ":",
    " Beyond",
    " GL",
    "P",
    "-",
    "1",
    "**",
    "  \n",
    "While",
    " GL",
    "P",
    "-",
    "1",
    " agon",
    "ists",
    " like",
    " Oz",
    "emp",
    "ic",
    " and",
    " Weg",
    "ovy",
    " (",
    "sem",
    "ag",
    "lut",
    "ide",
    ")",
    " dominate",
    " headlines",
    ",",
    " the",
    " next",
    " generation",
    " of",
    " weight",
    "-loss",
    " drugs",
    " is",
    " already",
    " in",
    " development",
    ".\n\n",
    "*",
    " **",
    "Recent",
    " News",
    ":**",
    " Companies",
    " are",
    " developing",
    " dual",
    "-",
    " and",
    " even",
    " triple",
    "-",
    "agon",
    "ist",
    " drugs",
    " that",
    " target",
    " multiple",
    " metabolic",
    " pathways",
    " simultaneously",
    " (",
    "e",
    ".g",
    ".,",
    " GL",
    "P",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " gluc",
    "agon",
    ").",
    " **",
    "E",
    "li",
    " Lilly",
    "'s",
    "**",
    " ret",
    "atr",
    "ut",
    "ide",
    " (",
    "target",
    "ing",
    " GL",
    "P",
    "-",
    "1",
    ",",
    " G",
    "IP",
    ",",
    " and",
    " gluc",
    "agon",
    " receptors",
    ")",
    " has",
    " shown",
    " remarkable",
    " efficacy",
    " in",
    " trials",
    ",",
    " surpass",
    "ing",
    " even",
    " their",
    " blockbuster",
    " drug",
    " M",
    "oun",
    "j",
    "aro",
    " (",
    "tir",
    "zep",
    "at",
    "ide",
    ").",
    " **",
    "Am",
    "gen",
    "**",
    " is",
    " also",
    " advancing",
    " its",
    " experimental",
    " candidate",
    ",",
    " Mari",
    "T",
    "ide",
    " (",
    "AM",
    "G",
    " ",
    "133",
    "),",
    " which",
    " uses",
    " a",
    " different",
    " mechanism",
    ".\n",
    "*",
    " **",
    "Why",
    " it",
    " matters",
    ":**",
    " This",
    " R",
    "&D",
    " race",
    " aims",
    " to",
    " create",
    " more",
    " effective",
    " treatments",
    " with",
    " potentially",
    " fewer",
    " side",
    " effects",
    ",",
    " moving",
    " from",
    " managing",
    " weight",
    " to",
    " potentially",
    " curing",
    " obesity",
    "-related",
    " com",
    "or",
    "bid",
    "ities",
    ".\n\n",
    "**",
    "C",
    ".",
    " Neu",
    "rology",
    ":",
    " Progress",
    " in",
    " Alzheimer's",
    " Disease",
    "**",
    "  \n",
    "The",
    " focus",
    " has",
    " shifted",
    " from",
    " targeting",
    " amy",
    "loid",
    " plaques",
    " alone",
    " to",
    " addressing",
    " other",
    " pathological",
    " drivers",
    " like",
    " tau",
    " protein",
    " and",
    " neuro",
    "in",
    "flammation",
    ".\n",
    "``",
    "`\n"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:44:02.891Z",
  "started_at": "2025-10-19T05:44:02.895672221Z",
  "completed_at": "2025-10-19T05:44:06.898190608Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/841thdgc9drma0cszbzrf0t1yc/cancel",
    "get": "https://api.replicate.com/v1/predictions/841thdgc9drma0cszbzrf0t1yc",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/byggfnmn64gfsh5b6gz7b4tvsbuv37kkugqr2qsfsilcvyl2wbja",
    "web": "https://replicate.com/p/841thdgc9drma0cszbzrf0t1yc"
  },
  "metrics": {
    "input_token_count": 629,
    "output_token_count": 508,
    "predict_time": 4.002518387,
    "time_to_first_token": 0.066846789,
    "tokens_per_second": 129.07581015096676
  }
}
[2025-10-19 05:44:07 UTC] --- REQUEST END ---

[2025-10-19 05:49:48 UTC] --- REQUEST START ---
[2025-10-19 05:49:48 UTC] Flattened prompt text:
[2025-10-19 05:49:48 UTC] System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.

User: what is oneliner for scaling up images with convert
Assistant: convert input.jpg -resize 200% output.jpg
User: how to use ripgrep in current dir to find all files with "echo" in them ?
Assistant: rg "echo"
User: how to install mdimg on macos
Assistant:
[2025-10-19 05:49:48 UTC] JSON body:
[2025-10-19 05:49:48 UTC] {
  "input": {
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: how to install mdimg on macos\nAssistant:",
    "temperature": 0.2,
    "max_tokens": 600
  }
}
[2025-10-19 05:49:50 UTC] Final status: succeeded
[2025-10-19 05:49:50 UTC] Final response JSON:
[2025-10-19 05:49:50 UTC] {
  "id": "swx12rahznrma0cszc29vsks1c",
  "model": "openai/gpt-4o",
  "version": "hidden",
  "input": {
    "max_tokens": 600,
    "prompt": "System: You are a precise assistant. Respond only with what the user explicitly requests. No introductory text, no explanations, no extra formatting. Provide exactly what they asked for and nothing more.\n\nUser: what is oneliner for scaling up images with convert\nAssistant: convert input.jpg -resize 200% output.jpg\nUser: how to use ripgrep in current dir to find all files with \"echo\" in them ?\nAssistant: rg \"echo\"\nUser: how to install mdimg on macos\nAssistant:",
    "temperature": 0.2
  },
  "logs": "WARNING unknown input field ignored: max_tokens\nInput token count: 112\nOutput token count: 4\nTotal token count: 116\nTTFT: 0.26s\nFinish reason: stop\n",
  "output": [
    "",
    "brew",
    " install",
    " md",
    "img"
  ],
  "data_removed": false,
  "error": null,
  "status": "succeeded",
  "created_at": "2025-10-19T05:49:48.413Z",
  "started_at": "2025-10-19T05:49:48.416111557Z",
  "completed_at": "2025-10-19T05:49:48.824300738Z",
  "urls": {
    "cancel": "https://api.replicate.com/v1/predictions/swx12rahznrma0cszc29vsks1c/cancel",
    "get": "https://api.replicate.com/v1/predictions/swx12rahznrma0cszc29vsks1c",
    "stream": "https://stream-b.svc.ric1.c.replicate.net/v1/streams/dr44534ekcyacwt2z5x4vqqlliryw737tbglfxzouyn2ae2e4kka",
    "web": "https://replicate.com/p/swx12rahznrma0cszc29vsks1c"
  },
  "metrics": {
    "input_token_count": 112,
    "output_token_count": 4,
    "predict_time": 0.408189182,
    "time_to_first_token": 0.089934052,
    "tokens_per_second": 12.568532673770255
  }
}
[2025-10-19 05:49:50 UTC] --- REQUEST END ---

